Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1050.Time spend outdoors in summer,46692,0.0131857827329242,0.0400088787455727,-0.0652316196083983,0.0916031850742467,0.74172764089016
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1060.Time spent outdoors in winter,44873,0.0596963066638871,0.044442016557863,-0.0274100457895243,0.146802659117299,0.179212916633906
LYZL2,Lysozyme-like protein 2,Physical activities,X1070.Time spent watching television (TV),47406,0.0125188286719464,0.0391244129742219,-0.0641650207575286,0.0892026781014214,0.748990941032603
LYZL2,Lysozyme-like protein 2,Physical activities,X1080.Time spent using computer,44865,0.0342524741437144,0.0392796864736588,-0.0427357113446569,0.111240659632086,0.383213090064615
LYZL2,Lysozyme-like protein 2,Physical activities,X1090.Time spent driving,42670,0.0111699262832781,0.04273371484062,-0.0725881548043372,0.0949280073708934,0.793799914458481
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1160.Sleep duration,48293,0.0169187860957123,0.0360149317873478,-0.0536704802074894,0.0875080523989139,0.638523528391021
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34631,-0.0275279509329729,0.0152699456451262,-0.0574570443974202,0.00240114253147435,0.0714768056375457
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34631,0.0274999701812937,0.0170105977028612,-0.00584080131631419,0.0608407416789017,0.106008852419707
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34631,0.00317594562577909,0.0179278961046861,-0.0319627307394057,0.0383146219909638,0.859395692412528
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34631,0.0370908178116939,0.018517704476494,0.000796117037765699,0.0733855185856221,0.0452227954587349
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34631,0.00997519930445684,0.0186761913881866,-0.026630135816389,0.0465805344253026,0.59328294250109
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34631,0.0330861185250239,0.0511363998625585,-0.0671412252055907,0.133313462255639,0.517645584125089
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34631,-0.0467467668717249,0.0592335540732518,-0.162844532855299,0.0693509991118486,0.430029637665641
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34631,0.0244982009042674,0.0302929463435289,-0.0348759739290493,0.083872375737584,0.418714021589781
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34631,0.00393506508830531,0.0236266333501722,-0.0423731362780323,0.0502432664546429,0.867728079489199
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34631,-0.00929406791601196,0.0154131278604833,-0.0395037985225593,0.0209156626905354,0.546533442784249
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34631,0.0351448912311081,0.0244344439724132,-0.0127466189548218,0.083036401417038,0.150391200983889
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34631,-0.0133369138804174,0.011569435947465,-0.0360130083374489,0.00933918057661397,0.249049949182419
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34631,0.0116058336719662,0.0156927584895025,-0.0191519729674588,0.0423636403113911,0.459592045358715
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34631,0.0572799532849405,0.0248944105024627,0.00848690870011364,0.106072997869767,0.0214303142031885
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34631,0.00271846950907787,0.0229991621347397,-0.0423598882750119,0.0477968272931677,0.90591420988298
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34631,0.0455687063628235,0.027872785487186,-0.00906195319206104,0.100199365917708,0.102126041793799
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34631,0.0362456913511522,0.0279026537906306,-0.0184435100784838,0.0909348927807883,0.193991816359383
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34631,0.0189554406530583,0.0176124734533678,-0.0155650073155427,0.0534758886216592,0.281858105146596
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34631,0.013566105298016,0.017242951397385,-0.0202300794408585,0.0473622900368905,0.431451899621711
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34631,0.0274240721030487,0.0192465370913516,-0.0102991405960004,0.0651472848020979,0.154242640098323
LYZL2,Lysozyme-like protein 2,Health and medical history,X120040.Fatigue severity over the past week,34640,-0.00757440713073038,0.0680253962300734,-0.140904183741674,0.125755369480214,0.911345081685646
LYZL2,Lysozyme-like protein 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,34642,-0.0370236818053869,0.0671557223668777,-0.168648897644467,0.0946015340336934,0.581440960251001
LYZL2,Lysozyme-like protein 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,34641,0.145774314514384,0.0735753910365442,0.00156654808275689,0.28998208094601,0.0476038487547587
LYZL2,Lysozyme-like protein 2,Health and medical history,X120098.Mobility problems today,34643,-0.0246793569182703,0.0792651886171825,-0.180039126607948,0.130680412771407,0.755543958762516
LYZL2,Lysozyme-like protein 2,Health and medical history,X120099.Self-care problems today,34643,-0.0964465306546507,0.120971594106779,-0.333550855103937,0.140657793794636,0.425327941401138
LYZL2,Lysozyme-like protein 2,Health and medical history,X120100.Problems doing usual activities,34643,-0.0948403521119712,0.076789293385702,-0.245347367147947,0.0556666629240046,0.216851527145181
LYZL2,Lysozyme-like protein 2,Health and medical history,X120101.Pain or discomfort today,34643,-0.0485039030666507,0.0674938841858179,-0.180791916070854,0.0837841099375524,0.472389663373925
LYZL2,Lysozyme-like protein 2,Health and medical history,X120102.Anxiety or depression today,34643,-0.12039563082501,0.0885883878839941,-0.294028871077638,0.0532376094276187,0.174182982245184
LYZL2,Lysozyme-like protein 2,Health and medical history,X120103.Scale to indicate how health is today,34630,-0.00118415383650842,0.00502586057808422,-0.0110348405695535,0.00866653289653665,0.813741642716267
LYZL2,Lysozyme-like protein 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34629,-0.0121354726042589,0.0853120597747575,-0.179347109762784,0.155076164554266,0.886888848179418
LYZL2,Lysozyme-like protein 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34627,-0.121701237485231,0.0923221380548965,-0.302652628072828,0.0592501531023659,0.187478860411868
LYZL2,Lysozyme-like protein 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34631,-0.0151426699424276,0.0686211525912262,-0.149640129021231,0.119354789136376,0.825356408125245
LYZL2,Lysozyme-like protein 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34636,0.0972446240113505,0.0692828396739952,-0.0385497417496802,0.233038989772381,0.160492765412144
LYZL2,Lysozyme-like protein 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34636,-0.00933152113819599,0.101055450137527,-0.207400203407748,0.188737161131356,0.926430495582055
LYZL2,Lysozyme-like protein 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,34624,-0.143953655071093,0.0978705281175867,-0.335779890181563,0.0478725800393766,0.141381755111705
LYZL2,Lysozyme-like protein 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,34640,0.139082555586132,0.0897825209285396,-0.0368911854338058,0.315056296606069,0.121408880748065
LYZL2,Lysozyme-like protein 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34634,-0.0602506542031343,0.138377864361756,-0.331471268352177,0.210969959945908,0.663282800800303
LYZL2,Lysozyme-like protein 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34602,-0.638957564236603,0.204420060452335,-1.03962088272318,-0.238294245750027,0.00178224253696114
LYZL2,Lysozyme-like protein 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",32333,-0.116177238231154,0.0967934176724429,-0.305892336869142,0.0735378604068341,0.230114699834976
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,46133,-0.179237154477429,0.0914228325366651,-0.358425906249292,-4.84027055650815e-05,0.0499497518356056
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,45122,-0.0141450690515302,0.0510555419150079,-0.114213931204946,0.0859237931018852,0.781743207288591
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1289.Cooked vegetable intake,47502,-0.0190977785588163,0.0378200929757304,-0.0932251607912479,0.0550296036736153,0.613590136274117
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,46806,-0.0279300521615183,0.0388076887124402,-0.103993122037901,0.0481330177148644,0.471716448565681
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1309.Fresh fruit intake,47382,0.0228319918978775,0.0396840618908722,-0.054948769408232,0.100612753203987,0.565065477020778
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1319.Dried fruit intake,46542,-0.029421746345743,0.0419631271356128,-0.111669475531544,0.0528259828400581,0.483228915985161
LYZL2,Lysozyme-like protein 2,Health and medical history,X134.Number of self-reported cancers,48420,-0.364285103393446,0.0844580356952176,-0.529822853356072,-0.198747353430819,1.61680415850738e-05
LYZL2,Lysozyme-like protein 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,48421,-0.0485369974235536,0.0373763728858579,-0.121794688279835,0.024720693432728,0.194095982771622
LYZL2,Lysozyme-like protein 2,Health and medical history,"X136.Number of operations, self-reported",48421,0.0509926570741563,0.0359537471459796,-0.0194766873319638,0.121462001480276,0.156123322743132
LYZL2,Lysozyme-like protein 2,Health and medical history,X137.Number of treatments or medications taken,48421,-0.014114733355467,0.0366464881376309,-0.0859418501052237,0.0577123833942896,0.700123576311875
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1438.Bread intake,47968,0.00657260973056947,0.0027143170995393,0.00125254821547245,0.0118926712456665,0.0154674357060729
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1458.Cereal intake,47391,0.0903499732171172,0.0375100077847992,0.0168303579589108,0.163869588475324,0.0160194613665981
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1488.Tea intake,47677,0.00488079839159094,0.00266886075309182,-0.000350168684469022,0.0101117654676509,0.0674459735396866
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1498.Coffee intake,46878,-0.043760965984344,0.0374380750413878,-0.117139593065464,0.0296176610967762,0.242463472873643
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1528.Water intake,46670,-0.0816057053832586,0.0379510118892467,-0.155989688686182,-0.00722172208033513,0.0315454596986723
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1568.Average weekly red wine intake,43685,-0.0596726582696208,0.0413386207880955,-0.140696355014288,0.0213510384750464,0.148897993971344
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,43688,-0.0700290599492401,0.0432277025372065,-0.154755356922165,0.0146972370236847,0.105252273164604
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,43741,0.0237322610228863,0.0430457758698009,-0.0606374596819234,0.108101981727696,0.581418265346314
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1598.Average weekly spirits intake,43686,-0.0523483548172803,0.0444714015038003,-0.139512301764729,0.0348155921301684,0.239164582369675
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1608.Average weekly fortified wine intake,43717,-0.105616459627559,0.0809364557885062,-0.264251912973031,0.0530189937179135,0.191936337218878
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1737.Childhood sunburn occasions,43212,0.00367615028360856,0.0440165692991283,-0.082596325542683,0.0899486261099001,0.933441271148692
LYZL2,Lysozyme-like protein 2,Health and medical history,X1807.Father's age at death,43355,-0.000336508610559833,0.00308643388958026,-0.00638591903413715,0.00571290181301748,0.913181534164578
LYZL2,Lysozyme-like protein 2,Health and medical history,X1845.Mother's age,35932,-0.00284556639468314,0.00691172620775419,-0.0163925497618814,0.0107014169725151,0.680570435100558
LYZL2,Lysozyme-like protein 2,Health and medical history,X1873.Number of full brothers,48087,0.0242059917006375,0.0360857902811241,-0.0465221572503657,0.0949341406516407,0.502362190850454
LYZL2,Lysozyme-like protein 2,Health and medical history,X1883.Number of full sisters,48088,0.0622832553666823,0.0361147966805228,-0.0085017461271423,0.133068256860507,0.0846170536312401
LYZL2,Lysozyme-like protein 2,Physical measures,X20015.Sitting height,48246,-0.00384243753267143,0.00349087793925644,-0.0106845582936141,0.0029996832282712,0.271037217190664
LYZL2,Lysozyme-like protein 2,Cognitive function,X20016.Fluid intelligence score,35035,0.0452832132109468,0.0587089344908891,-0.0697862983911957,0.160352724813089,0.44054729081523
LYZL2,Lysozyme-like protein 2,Cognitive function,X20018.Prospective memory result,35331,-0.129007611794272,0.0814275760442854,-0.288605660841072,0.0305904372525269,0.113167134982697
LYZL2,Lysozyme-like protein 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),34960,-0.00540729231820725,0.00470693220531339,-0.0146328794406215,0.003818294804207,0.250684413186219
LYZL2,Lysozyme-like protein 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),34965,-0.0111034386374138,0.0046976216654345,-0.0203107771016654,-0.00189610017316214,0.018126759868457
LYZL2,Lysozyme-like protein 2,Cognitive function,X20023.Mean time to correctly identify matches,48173,0.002392913266535,0.00273788296747686,-0.00297333734971965,0.00775916388278964,0.382128270214916
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,45545,-0.00498010543565001,0.00614861631969426,-0.0170313934222508,0.00707118255095074,0.417977141757679
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,45176,-0.0324285834981185,0.0137476844379384,-0.0593740449964779,-0.00548312199975914,0.0183437107325461
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,45143,-0.0100414192634057,0.018051015416655,-0.0454214094800495,0.0253385709532381,0.578026965824454
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,45164,-0.00498516345570259,0.0162670630842841,-0.0368686071008994,0.0268982801894943,0.75926018742222
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,45185,0.011764014968683,0.0108981652324061,-0.00959638888683298,0.033124418824199,0.280403257591277
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#2.Illnesses of father_Stroke,45325,0.010955152053491,0.00784906644695854,-0.00442901818254769,0.0263393222895298,0.162815321822134
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,45287,0.0192070601478708,0.00995919066622637,-0.000312953557932868,0.0387270738536745,0.0538004127766077
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,45189,-0.0118552685470508,0.0120987420018843,-0.035568802870744,0.0118582657766424,0.327161554247213
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,45304,0.00583960923644859,0.00930257264152782,-0.0123934331409459,0.0240726516138431,0.530181993016719
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,45376,0.000789295477111067,0.00698190920369416,-0.0128952465621295,0.0144738375163516,0.90999333031896
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,45255,0.0216566105378301,0.00955998983502555,0.00291903046118006,0.0403941906144802,0.0235047173568479
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46175,0.0018989680282047,0.00730408919777896,-0.0124170467994421,0.0162149828558515,0.794876869083026
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46049,-0.000554696234911412,0.0102807603837832,-0.0207049865871265,0.0195955941173037,0.956971804306653
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,45979,0.0135607135724378,0.0231003910217763,-0.0317160528302438,0.0588374799751194,0.557188537709748
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46009,0.0228177074015995,0.0121753461225312,-0.00104597099856159,0.0466813858017605,0.0609346093396091
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,46128,-0.0198035166746939,0.00823070010331401,-0.0359356888771894,-0.00367134447219846,0.0161361247389523
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46050,-0.0123337307754145,0.0138106885329626,-0.0394026803000213,0.0147352187491922,0.371839014465697
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46017,0.0054320758191779,0.0124744695500224,-0.0190178844988659,0.0298820361372217,0.663237261309632
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46025,-0.0108934064828203,0.0105282069842486,-0.0315286921719475,0.00974187920630688,0.300829131793431
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46056,0.0168896385427744,0.0123945133803373,-0.00740360768268666,0.0411828847682354,0.173003937839544
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46226,-0.0045946556529769,0.00627867417788166,-0.016900857041625,0.00771154573567116,0.464307972626924
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46102,0.00046873135426686,0.00946949797192984,-0.0180914846707156,0.0190289473792493,0.960522142204522
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43647,0.0110029767505475,0.0101128780908791,-0.00881826430757564,0.0308242178086706,0.276605314442948
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43524,0.0324088572351831,0.0421737683377098,-0.0502517287067281,0.115069443177094,0.442226060307715
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43519,-0.00136531985878083,0.0396344930762373,-0.079048926288206,0.0763182865706443,0.972520552810057
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43566,-0.00463059209894093,0.0132371134686195,-0.0305753344974351,0.0213141502995532,0.726479557615515
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43532,-0.0043709590263212,0.0236010370888805,-0.050628991720527,0.0418870736678846,0.853073123958022
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43562,0.0224621544112632,0.017011711403893,-0.0108807999403672,0.0558051087628935,0.186723845685685
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43536,0.0485402946398665,0.0193206600923387,0.0106718008588827,0.0864087884208504,0.0120033999124121
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43543,-0.0199219428908872,0.0189111712324414,-0.0569878385064723,0.0171439527246979,0.292152569440997
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43548,0.00520722808437854,0.0148592701961085,-0.0239169414999941,0.0343313976687512,0.726016204787981
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43562,-0.0178170310171786,0.0188591473193039,-0.0547809597630143,0.0191468977286571,0.344805798062728
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43704,0.00589801651488895,0.00769889639849711,-0.00919182042616539,0.0209878534559433,0.443637122452801
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43621,-0.00280510870742648,0.0107053059484479,-0.0237875083663844,0.0181772909515314,0.79330209434275
LYZL2,Lysozyme-like protein 2,Mental health,X20127.Neuroticism score,44529,0.00204855576953531,0.0375674413489737,-0.0715836292744532,0.0756807408135238,0.956513524220584
LYZL2,Lysozyme-like protein 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,35035,-0.0269626227046635,0.0599966735722011,-0.144556102906178,0.0906308574968507,0.653156878815914
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X20161.Pack years of smoking,35592,-0.00580167973480423,0.00458522086039517,-0.0147887126211788,0.0031853531515703,0.20580598797635
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,35592,-0.00647467548846389,0.00452151127402977,-0.0153368375855622,0.00238748660863445,0.152196664619471
LYZL2,Lysozyme-like protein 2,Cognitive function,X20191.Fluid intelligence score,33190,-0.0910751742406788,0.0715219978892208,-0.231258290103552,0.049107941622194,0.202945440594164
LYZL2,Lysozyme-like protein 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,33191,-0.0676342790894017,0.0737583747966251,-0.212200693690787,0.0769321355119835,0.359206210911735
LYZL2,Lysozyme-like protein 2,Cognitive function,X20240.Maximum digits remembered correctly,32756,-0.0272975303570722,0.0771921224637981,-0.178594090386116,0.123999029671972,0.723633382856165
LYZL2,Lysozyme-like protein 2,Physical measures,X20255.Spirometry QC measure,42689,-0.00894285237116678,0.0455512620159073,-0.0982233259223451,0.0803376211800115,0.844358611421545
LYZL2,Lysozyme-like protein 2,Eye measures,X20261.avMSE,33042,0.00168694981164722,0.00574509192154222,-0.00957343035457554,0.01294732997787,0.769051910052208
LYZL2,Lysozyme-like protein 2,Eye measures,X20262.Myopia diagnosis,33042,0.0162439244351244,0.091459198144391,-0.163016103927882,0.195503952798131,0.859038605035845
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X20280.Glucose-lactate,39539,0.00351427440146996,0.00347986121522427,-0.00330625358036961,0.0103348023833095,0.312570695029332
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,39557,0.00894101429095058,0.00368484079106983,0.00171872634045371,0.0161633022414474,0.0152641489001163
LYZL2,Lysozyme-like protein 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,34705,0.0408985394193192,0.0229228368960007,-0.00403022089684207,0.0858272997354805,0.0744435579903022
LYZL2,Lysozyme-like protein 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,34705,-0.00126746696109524,0.0499234556697203,-0.0991174400737469,0.0965825061515564,0.979746148345671
LYZL2,Lysozyme-like protein 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),34707,0.00127318044624696,0.0588082922986288,-0.113991072459065,0.116537433351559,0.982728114755257
LYZL2,Lysozyme-like protein 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),34707,0.0187003947040948,0.0222503837068121,-0.0249103573612569,0.0623111467694465,0.400687523592819
LYZL2,Lysozyme-like protein 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),34707,-0.0202125744846683,0.0308492578537525,-0.0806771198780232,0.0402519709086866,0.512360735873601
LYZL2,Lysozyme-like protein 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,34709,-0.0244610836020432,0.0423836790447834,-0.107533094529819,0.0586109273257321,0.563869864002605
LYZL2,Lysozyme-like protein 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,34709,0.0136175714122131,0.0276546441415937,-0.0405855311053106,0.0678206739297368,0.622443442159751
LYZL2,Lysozyme-like protein 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,34709,-0.0142051958281216,0.0309066619717991,-0.0747822532928479,0.0463718616366046,0.64580823986175
LYZL2,Lysozyme-like protein 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,34709,0.13138242077675,0.0453412064293027,0.0425136561753172,0.220251185378184,0.00377320607794998
LYZL2,Lysozyme-like protein 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,34709,0.08020970431585,0.0485770399918765,-0.0150012940682279,0.175420702699928,0.0987521012604413
LYZL2,Lysozyme-like protein 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,34709,-0.0130103588239976,0.032768574542522,-0.0772367649273406,0.0512160472793455,0.691353544452767
LYZL2,Lysozyme-like protein 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,34709,0.130810945659626,0.0470497448345543,0.0385934457838997,0.223028445535352,0.00544801536720771
LYZL2,Lysozyme-like protein 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,34709,0.0836385407044829,0.0374207328710161,0.0102939042772913,0.156983177131675,0.0254477334687002
LYZL2,Lysozyme-like protein 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),34711,0.055655600113909,0.0644431739822829,-0.0706530208913655,0.181964221119184,0.387820453536301
LYZL2,Lysozyme-like protein 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),34711,0.0401398924581754,0.0296961108621861,-0.0180644848317093,0.09834426974806,0.176525004466773
LYZL2,Lysozyme-like protein 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),34711,0.00550353412259528,0.0377326930385207,-0.0684525442329054,0.0794596124780959,0.884039993797792
LYZL2,Lysozyme-like protein 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,34711,0.0978708237512165,0.0783742661720851,-0.0557427379460703,0.251484385448503,0.211799885792101
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20600.Liking for adding salt to foods,35146,-0.0237766867577575,0.0593817159802035,-0.140164850078956,0.0926114765634414,0.688871937116377
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20601.Liking for aniseed,35146,-3.26099706272142e-05,0.0596292599928385,-0.116905959556591,0.116840739615336,0.99956367065849
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20602.Liking for apple juice,35146,-0.0127382276307507,0.0594325443821727,-0.129226014619809,0.103749559358308,0.830295748884858
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20603.Liking for apples,35146,0.0892971582205047,0.0608002940893675,-0.0298714181946556,0.208465734635665,0.1419633378955
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20604.Liking for asparagus,35146,-0.0660460022797321,0.060147163808886,-0.183934443345149,0.0518424387856845,0.272212871023815
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20605.Liking for aubergine,35146,-0.122772792192388,0.0601587414974958,-0.24068392552748,-0.00486165885729621,0.0413094216823897
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20606.Liking for avocados,35146,-0.0289028680701556,0.059534598418518,-0.145590680970451,0.0877849448301396,0.627352032788406
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20607.Liking for bacon,35146,-0.0590629164993417,0.0607412345440036,-0.178115736205589,0.0599899032069054,0.330902797792665
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20608.Liking for baked or steamed fish,35146,0.0651292257604895,0.0601391598523089,-0.0527435275500358,0.183001979071015,0.278859322691853
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20609.Liking for bananas,35146,0.0981974592572202,0.0610090204208437,-0.0213802207676335,0.217775139282074,0.107543018695014
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35146,-0.0245156322858914,0.0603056700622148,-0.142714745607832,0.0936834810360496,0.684371786261486
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20611.Liking for beef steak,35146,-0.021016285750092,0.0602174986808916,-0.13904258316464,0.0970100116644556,0.727095828820468
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20612.Liking for beetroot,35146,0.0466730957885831,0.0598858531770955,-0.0707031764385241,0.16404936801569,0.43579139676342
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20613.Liking for bell pepper,35146,-0.0256768935239104,0.0594668823753258,-0.142231982979549,0.0908781959317282,0.665912097411388
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20614.Liking for bicycling,35146,0.0293475978389436,0.0588200233659305,-0.0859396479582803,0.144634843636167,0.617839216546423
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20615.Liking for biscuits,35146,0.100535142237676,0.059218623550543,-0.0155333599213881,0.21660364439674,0.0896129989656059
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20616.Liking for bitter foods,35146,0.0115690362129153,0.0597229401490752,-0.105487926479272,0.128625998905103,0.846407596989483
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20617.Liking for bitter or ale,35146,0.0580103064456534,0.0595401810572416,-0.0586884484265401,0.174709061317847,0.329941087881887
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20618.Liking for black olives,35146,-0.0332058901404777,0.0599337816007526,-0.150676102077953,0.0842643217969975,0.579568392420903
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20619.Liking for black pepper,35146,-0.0411669074689974,0.0606010902414502,-0.15994504434224,0.0776112294042451,0.496965713049829
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20620.Liking for blue cheese,35146,-0.0593347727208405,0.059893117044617,-0.17672528212829,0.0580557366866087,0.321879673141085
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20621.Liking for bolognese sauce,35146,0.0265507634910429,0.0600383751233569,-0.0911244517507366,0.144225978732822,0.658337495338785
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20622.Liking for broad beans,35146,0.0751648665748271,0.0599770974166349,-0.0423902443617772,0.192719977511431,0.210168240279867
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20623.Liking for broccoli,35146,-0.0191154821852667,0.0604605321079582,-0.137618125116865,0.0993871607463313,0.751887641965761
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20624.Liking for brown rice,35146,0.0379570031023852,0.0595917381575485,-0.0788428036864098,0.15475680989118,0.524179219986558
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20625.Liking for brussel sprouts,35146,0.0245561518239286,0.0594086265518904,-0.0918847562177765,0.140997059865634,0.679368741308108
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20626.Liking for burgers (meat),35146,-0.0780438338608909,0.059021358952033,-0.193725697406876,0.0376380296850937,0.1861151504711
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20627.Liking for burn of spicy foods,35146,-0.0387274720653091,0.0591059770633594,-0.154575187109494,0.0771202429788753,0.512348589449763
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20628.Liking for butter on bread,35146,0.12883565806488,0.0609204308844927,0.00943161353127407,0.248239702598485,0.0344831563884846
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20629.Liking for butternut squash,35146,-0.0391835092981072,0.0599678490453138,-0.156720493426922,0.0783534748307079,0.513515866306563
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20630.Liking for cabbage,35146,-0.00923556671109891,0.0599940991225502,-0.126824000991297,0.108352867569099,0.877660809608361
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20631.Liking for cake,35146,0.0513986993376283,0.0588740050000387,-0.0639943504624474,0.166791749137704,0.382679471322918
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20632.Liking for cake icing,35146,-0.0121808440551232,0.0585570854682578,-0.126952731572909,0.102591043462662,0.835222509780565
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20633.Liking for capers,35146,-0.0195085989055489,0.0594028291763243,-0.135938144091144,0.0969209462800467,0.742610728561213
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20634.Liking for cauliflower,35146,0.0633665492109439,0.0604184173728627,-0.0550535488398669,0.181786647261755,0.294311136986658
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20635.Liking for cereal or granola bar,35146,0.0785799658854069,0.059824719790461,-0.0386764849038966,0.19583641667471,0.189059513610759
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20636.Liking for cheesecake,35146,0.129905699768458,0.0596195791783609,0.0130513245788705,0.246760074958045,0.0293739440911457
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20637.Liking for cherries,35146,0.0429004503837396,0.0607421521954431,-0.0761541679193289,0.161955068686808,0.480044489704301
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20638.Liking for chicken,35146,0.0186514171947586,0.0617194463813765,-0.102318697712739,0.139621532102257,0.76251168222658
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20639.Liking for chilli pepper,35146,-0.0490893474212402,0.0600515244818762,-0.166790335405718,0.0686116405632371,0.413698928171299
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20640.Liking for chips or french fries,35146,0.0565537742082099,0.0602671463460696,-0.0615698326300866,0.174677381046506,0.348081362402501
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20641.Liking for cigarette smoking,35146,-0.0200197920448,0.0934480087565235,-0.203177889207586,0.163138305117986,0.830370836951361
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20642.Liking for cod,35146,0.162593778061235,0.0612809421170215,0.0424831315118725,0.282704424610597,0.00799131366640003
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20643.Liking for coffee with sugar,35146,-0.00996689526756737,0.0618407381089213,-0.131174741961053,0.111240951425918,0.871964189871418
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20644.Liking for coffee without sugar,35146,0.0888029927514821,0.0606210941360337,-0.030014351755144,0.207620337258108,0.14300011076282
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20645.Liking for coriander,35146,-0.0786444905862787,0.0596569345730086,-0.195572082349375,0.0382831011768181,0.187456419745381
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20646.Liking for corn flakes,35146,0.107118145858182,0.059641865709362,-0.00977991093216743,0.224016202648532,0.0725370638077349
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20647.Liking for cream,35146,0.089828659226699,0.0604470332836347,-0.028647526009225,0.208304844462623,0.137308233847216
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20648.Liking for croissant,35146,0.0280834383724521,0.0596329521240626,-0.0887971477907107,0.144964024535615,0.637700543163038
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20649.Liking for cucumber,35146,-0.0269446647145899,0.0588712182581308,-0.142332252500526,0.0884429230713464,0.64719164413417
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20650.Liking for curry,35146,0.0140889161880329,0.0605924030284294,-0.104672193747689,0.132850026123755,0.816141810580341
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20651.Liking for dairy products,35146,0.101779078398584,0.0606676211186586,-0.0171294589939867,0.220687615791155,0.0934631097393734
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20652.Liking for dark chocolate,35146,-0.105852001271233,0.0596728422855925,-0.222810772150994,0.0111067696085281,0.0761308191651276
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,35146,0.00792846611695661,0.0602862524713521,-0.110232588726893,0.126089520960807,0.895373023181414
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20654.Liking for dried fruit,35146,0.075439048104703,0.0595966554009886,-0.0413703964812347,0.192248492690641,0.205620181557715
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20655.Liking for eggs,35146,0.0694581039549658,0.0611099607096522,-0.0503174190359524,0.189233626945884,0.255743627143803
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20656.Liking for exercising alone,35146,0.0791228627141193,0.0593250909400069,-0.0371543155282942,0.195400040956533,0.182343196468715
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20657.Liking for exercising with others,35146,-0.0144733860088104,0.0585403318663035,-0.129212436466765,0.100265664449144,0.80473191566251
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,35146,-0.0643630062612024,0.0597263147703671,-0.181426583211122,0.0527005706887171,0.28123764412186
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20659.Liking for fatty foods,35146,-0.0287156042671292,0.0597162702259783,-0.145759493910047,0.0883282853757883,0.630626876657219
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20660.Liking for fresh tomatoes,35146,0.0278256453823625,0.0621105545993162,-0.0939110416322973,0.149562332397022,0.654166684566267
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20661.Liking for fried chicken,35146,0.0514624170161655,0.0594864662905402,-0.0651310569132933,0.168055890945624,0.38700942285664
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20662.Liking for fried or battered fish,35146,0.0777380515221009,0.0604014455026985,-0.0406487816631881,0.19612488470739,0.198131830567652
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20663.Liking for fruit,35146,0.0909082662083795,0.0634811962154307,-0.0335148783738646,0.215331410790624,0.152177237785819
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20664.Liking for garlic,35146,0.0249198463624032,0.0597924298795182,-0.0922733162014525,0.142113008926259,0.67685843149242
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20665.Liking for gherkins,35146,-0.0490094983553209,0.0596235365528852,-0.165871629998976,0.0678526332883341,0.411116886322089
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20666.Liking for globe artichoke,35146,-0.00234447990698231,0.0594650931304597,-0.118896062442683,0.114207102628719,0.968551832373398
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20667.Liking for goat's cheese,35146,0.0291127496827215,0.0591372474072021,-0.0867962552353946,0.145021754600838,0.62252999431478
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20668.Liking for going to a cafe,35146,-0.0862026449872999,0.0592739412372219,-0.202379569812255,0.029974279837655,0.145908578824353
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20669.Liking for going to the gym,35146,-0.0432034777092582,0.0585867149565324,-0.158033439024062,0.0716264836055454,0.460888646437528
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20670.Liking for going to the pub,35146,-0.0713020059142044,0.0594089706663335,-0.187743588420218,0.0451395765918093,0.230109355061407
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20671.Liking for grapefruit,35146,0.0828597457751234,0.0588678087437222,-0.0325211593625721,0.198240650912819,0.159310089613318
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20672.Liking for green olives,35146,-0.0528462921653743,0.0591180469557264,-0.168717664198598,0.0630250798678494,0.371402242460129
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20673.Liking for haddock,35146,-0.037332644070979,0.0608522699574624,-0.156603093187605,0.0819378050456472,0.539569556777082
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20674.Liking for ham,35146,0.0878828421441641,0.059983290262139,-0.0296844067696283,0.205450091057956,0.142935709742095
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20675.Liking for hard cheese,35146,0.0179245927682318,0.0612482365853008,-0.102121950938958,0.137971136475421,0.769795281400792
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20676.Liking for herring,35146,-0.118669324326939,0.0596804153799351,-0.235642938471612,-0.00169571018226623,0.0468076441212441
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20677.Liking for honey,35146,-0.0918897154474847,0.0598469334761154,-0.209189705060671,0.0254102741657015,0.124730989563265
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,35146,-0.140926866671756,0.0592152740433574,-0.256988803796736,-0.0248649295467755,0.0173455010659257
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20679.Liking for ice cream,35146,0.0381646855713849,0.0599304032355928,-0.0792989047703769,0.155628275913147,0.524266502897924
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20680.Liking for jam,35146,0.0399752851378182,0.0593800594632166,-0.0764096314100863,0.156360201685723,0.500837120784661
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20681.Liking for kiwi fruit,35146,0.0222392734072577,0.0587008450023431,-0.0928143827973349,0.13729292961185,0.704805761799753
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20682.Liking for lager,35146,-0.0365071060280518,0.0592486138247126,-0.152634389124488,0.0796201770683848,0.537805032077765
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20683.Liking for lamb,35146,0.00240831730366598,0.0607450532713247,-0.116651987108131,0.121468621715462,0.968376315911054
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20684.Liking for lemons,35146,0.0325611873078578,0.0596214957992168,-0.0842969444586072,0.149419319074323,0.584994066015438
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20685.Liking for lentils or beans,35146,0.0157277964743829,0.0598617236815915,-0.101601181941536,0.133056774890302,0.792762776495057
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20686.Liking for liver,35146,-0.0320421949901162,0.0600418244649364,-0.149724170941392,0.0856397809611592,0.593591764342075
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20687.Liking for mackerel,35146,0.011048257896007,0.0597217987326714,-0.106006467620029,0.128102983412043,0.853238384538822
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20688.Liking for marzipan,35146,0.116804181481398,0.0599379826206781,-0.000674264455130885,0.234282627417927,0.0513679352392627
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20689.Liking for mayonnaise,35146,0.0211499723175177,0.0598755451223772,-0.0962060961223417,0.138506040757377,0.723925737327981
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20690.Liking for melon,35146,0.0257586511603131,0.0599853218856102,-0.0918125797354829,0.143329882056109,0.667634734894936
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20691.Liking for milk chocolate,35146,0.0979088092498159,0.0588099486095612,-0.0173586900249241,0.213176308524556,0.0959937765904585
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20692.Liking for mushrooms,35146,0.0127626877761697,0.0612576686325641,-0.107302342743656,0.132827718295995,0.834966613467873
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20694.Liking for orange juice,35146,0.0992236092013374,0.0597776188893581,-0.0179405238218045,0.216387742224479,0.0969867786404546
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20695.Liking for oranges,35146,0.0483922503001985,0.0605051391605757,-0.0701978224545299,0.166982323054927,0.423853446535319
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20696.Liking for pasta,35146,0.109814955736038,0.0601412699587918,-0.00806193338319366,0.22769184485527,0.0679033780875016
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20697.Liking for pears,35146,0.113265687598099,0.0601494667132238,-0.00462726715981991,0.231158642356017,0.0597351739581768
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20698.Liking for pizza,35146,0.0128586862359232,0.0598677583247628,-0.104482120080612,0.130199492552458,0.829941781410577
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20699.Liking for plain yogurt,35146,0.0412415198039678,0.0591285544623548,-0.0746504469422477,0.157133486550183,0.485521589721636
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20700.Liking for plums,35146,-0.0291508870982192,0.0609194409326602,-0.148552991326233,0.0902512171297949,0.632299460779101
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20701.Liking for pollock,35146,0.0209061410920765,0.059277131613968,-0.0952770368713008,0.137089319055454,0.724336154537703
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20702.Liking for pork chop,35146,0.010349934300201,0.0592549883797188,-0.105789842924048,0.12648971152445,0.861346134995757
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20703.Liking for porridge,35146,0.118102070203239,0.0602948159497101,-7.5769058192815e-05,0.236279909464671,0.0501853049987863
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20704.Liking for potato crisps,35146,-0.0477345116203168,0.0599204709998543,-0.165178634780031,0.0697096115393976,0.425694231668134
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20705.Liking for potatoes,35146,0.0950323402801883,0.0604065524685662,-0.0233645025582014,0.213429183118578,0.115718020856572
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20706.Liking for prawns,35146,0.00602582850347225,0.0609683730410971,-0.113472182657078,0.125523839664023,0.921272056943426
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20707.Liking for raw carrots,35146,0.0731017154710147,0.059393547024345,-0.0433096366967016,0.189513067638731,0.218441090691616
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20708.Liking for red meat,35146,-0.0561326329944421,0.0600076886476632,-0.173747702743862,0.0614824367549778,0.349604379422122
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20709.Liking for red wine,35146,-0.053123436395852,0.0602015781520226,-0.171118529573816,0.0648716567821122,0.377578940321107
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35146,-0.0437310690081574,0.0604525750272553,-0.162218116061578,0.0747559780452629,0.469463343778412
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20711.Liking for roast chicken,35146,0.00440469469710736,0.0618853988609708,-0.116890687070395,0.12570007646461,0.943260636908093
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20712.Liking for salad dressing,35146,-0.0596795457424848,0.0595330009062421,-0.176364227518719,0.0570051360337497,0.316157821914317
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20713.Liking for salad leaves,35146,0.0193677974045598,0.0598803232452318,-0.0979976361560945,0.136733230965214,0.746371050624063
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20714.Liking for salami,35146,-0.0462571209327715,0.0598011347325562,-0.163467345008582,0.0709531031430388,0.43924516826324
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20715.Liking for salmon,35146,-0.0404391010926092,0.0607968187001722,-0.159600865744947,0.0787226635597283,0.505977000887942
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20716.Liking for salty foods,35146,0.00865852299401431,0.0596880016485648,-0.108329960237173,0.125647006225201,0.884665571295762
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20717.Liking for salty pretzels,35146,-0.0828599772629467,0.0592689908006544,-0.199027199232229,0.033307244706336,0.162150730481085
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20718.Liking for sardines,35146,-0.00325495536729822,0.0601303124068793,-0.121110367684782,0.114600456950185,0.956831899292433
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20719.Liking for sausages (meat),35146,-0.074861371410595,0.0600306355167999,-0.192521417023523,0.0427986742023327,0.212422819848285
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20720.Liking for savoury biscuits,35146,-0.0184786763115097,0.0599845566350516,-0.136048407316211,0.0990910546931914,0.758048600740054
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35146,-0.0523734416487561,0.060156759320648,-0.170280689917226,0.0655338066197138,0.383995785983192
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20722.Liking for skimmed milk,35146,0.125414567086071,0.0595010381051112,0.00879253240005291,0.242036601772089,0.0350887685126283
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20723.Liking for smoked fish,35146,-0.0947111628113483,0.0600777478533647,-0.212463548603943,0.0230412229812464,0.114964399510533
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20724.Liking for soft cheese,35146,0.0254616946703787,0.0592801797160484,-0.0907274575730762,0.141650846913834,0.667563025415525
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20725.Liking for soy sauce,35146,-0.0575085696066219,0.0588605708066035,-0.172875288387565,0.057858149174321,0.32859023537138
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20726.Liking for soya milk,35146,0.0210221030821404,0.0603305403447283,-0.097225755993527,0.139269962157808,0.727514396183298
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20727.Liking for spicy foods,35146,-0.00169321468423807,0.0600448048863864,-0.119381032261555,0.115994602893079,0.977504146409793
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20728.Liking for spinach,35146,-0.0102537870495535,0.0594365846638914,-0.126749492990781,0.106241918891674,0.863036891029184
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20729.Liking for spirits,35146,0.0491109960247538,0.0587222749684398,-0.0659846629133882,0.164206654962896,0.403001805667501
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20730.Liking for strawberries,35146,-0.030094130043037,0.0617416373761901,-0.15110773930037,0.0909194792142956,0.625976825141232
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35146,0.127603550918611,0.0596415878754002,0.0107060386828271,0.244501063154396,0.0324316142123975
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20732.Liking for sweet foods,35146,0.0625182795341865,0.0592908621983483,-0.0536918103745762,0.178728369442949,0.291723398510072
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20733.Liking for taking the stairs,35146,0.0871076780876644,0.0606855057306867,-0.0318359131444815,0.20605126931981,0.151222383241102
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20734.Liking for tea with sugar,35146,-0.0360913026904845,0.065670624118617,-0.164805725962974,0.0926231205820048,0.582625824557141
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20735.Liking for tea without sugar,35146,0.0138149958951548,0.061668604690322,-0.107055469297876,0.134685461088186,0.822748803921466
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20736.Liking for tomato ketchup,35146,-0.0029825032428682,0.0591947306497393,-0.119004175316357,0.113039168830621,0.959817441968488
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20737.Liking for tinned tuna,35146,0.0397967697590586,0.0594971985500021,-0.0768177393989456,0.156411278917063,0.503592608296163
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20738.Liking for turnip (white),35146,0.0206430043684723,0.0585631688651773,-0.0941408066072752,0.13542681534422,0.724481246135487
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20739.Liking for vegetables,35146,0.0426797062245912,0.0620757225770867,-0.0789887100264987,0.164348122475681,0.491765232400513
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20740.Liking for vinegar,35146,-0.0477615076899611,0.0592362421457964,-0.163864542295722,0.0683415269157998,0.420105783613789
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20741.Liking for watching television,35146,0.0651156348111585,0.0600378896259554,-0.0525586288557142,0.182789898478031,0.278149629861355
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20742.Liking for whisky,35146,0.0692565638486798,0.0589214054750755,-0.0462293908824682,0.184742518579828,0.239875198399429
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20743.Liking for white bread,35146,0.00286039842271071,0.0591912958285149,-0.113154541401178,0.1188753382466,0.961458989031337
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20744.Liking for white rice,35146,0.0376050352616211,0.0594689186284435,-0.0789540452501282,0.15416411577337,0.527181801826912
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20745.Liking for white wine,35146,-0.0663968680826552,0.0597690289395997,-0.183544164804271,0.0507504286389603,0.266656187276391
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35146,0.155222707336022,0.0608115373450173,0.0360320941397881,0.274413320532256,0.0107171882822178
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20747.Liking for whole milk,35146,0.0805952093914506,0.0594306655208419,-0.0358888950293995,0.197079313812301,0.175107319781649
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20748.Liking for wholemeal bread,35146,0.113116741656248,0.0616781155317722,-0.00777236478602501,0.234005848098522,0.0667016462561521
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20749.Liking for working up a sweat,35146,0.00748463955308653,0.059573539314739,-0.109279497503802,0.124248776609975,0.900023152794062
LYZL2,Lysozyme-like protein 2,Physical measures,X21001.Body mass index (BMI),48305,0.0317781217452428,0.0140252375682799,0.00428865611141419,0.0592675873790714,0.023475575432828
LYZL2,Lysozyme-like protein 2,Physical measures,X21002.Weight,48329,-0.0136492797842888,0.00677125378433943,-0.026920937201594,-0.000377622366983476,0.0438377243153607
LYZL2,Lysozyme-like protein 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,35316,-0.00757437960588289,0.00503771467832554,-0.017448300375401,0.00229954116363517,0.132748196022543
LYZL2,Lysozyme-like protein 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34965,-0.0797814015868863,0.0674308171608779,-0.211945803222207,0.0523830000484343,0.23679022517644
LYZL2,Lysozyme-like protein 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34967,-0.0462875176080508,0.0674471217708056,-0.17848387627883,0.085908841062728,0.492562430712469
LYZL2,Lysozyme-like protein 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34968,0.0233879110061738,0.0655364899158155,-0.105063609228825,0.151839431241172,0.721202057786085
LYZL2,Lysozyme-like protein 2,Health and medical history,X21040.Satisfaction with bowel habits,34944,0.0148553818789562,0.0603896563270996,-0.103508344522159,0.133219108280071,0.805696272374145
LYZL2,Lysozyme-like protein 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34940,0.0317755145230673,0.0670246803981694,-0.0995928590573448,0.163143888103479,0.635454378868285
LYZL2,Lysozyme-like protein 2,Health and medical history,X21042.Greatest number of times bowels opened per day,34939,-0.0658206716228108,0.0654161271179631,-0.194036280774018,0.0623949375283968,0.314365396747675
LYZL2,Lysozyme-like protein 2,Health and medical history,X21043.Least number of times bowels opened per week,34911,0.0715969586714585,0.065360062929897,-0.0565087646711396,0.199702682014057,0.273372886079538
LYZL2,Lysozyme-like protein 2,Health and medical history,X21044.Average number of times bowels opened per day,34922,-0.0414416442994209,0.0718977754114909,-0.182361284105943,0.0994779955071014,0.564367584354376
LYZL2,Lysozyme-like protein 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34971,-0.0636254870249155,0.0657209050832288,-0.192438460988044,0.065187486938213,0.333022987657058
LYZL2,Lysozyme-like protein 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34966,1.22885533672178e-05,0.0661251111657411,-0.129592929331485,0.12961750643822,0.99985172861449
LYZL2,Lysozyme-like protein 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34971,0.05158510281908,0.0766260311490376,-0.0986019182330337,0.201772123871194,0.50084067630943
LYZL2,Lysozyme-like protein 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34970,-0.0567449975679495,0.0952764528161393,-0.243486845087582,0.129996849951684,0.551475265187587
LYZL2,Lysozyme-like protein 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34969,-0.015368609923187,0.0811443564145201,-0.174411548495646,0.143674328649272,0.849786627600476
LYZL2,Lysozyme-like protein 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34967,0.0458198004841251,0.197299172923808,-0.340886578446538,0.432526179414788,0.8163628532431
LYZL2,Lysozyme-like protein 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34971,0.0468708373387092,0.0826843579346987,-0.1151905042133,0.208932178890719,0.570826134617255
LYZL2,Lysozyme-like protein 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34969,-0.00750258554227068,0.0753843063209361,-0.155255825931305,0.140250654846764,0.920724967490045
LYZL2,Lysozyme-like protein 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34851,0.0255634359305299,0.0758083788674337,-0.12302098664964,0.1741478585107,0.735969004851345
LYZL2,Lysozyme-like protein 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34968,0.0151604686042825,0.0681659505447786,-0.118444794463483,0.148765731672048,0.824005520795697
LYZL2,Lysozyme-like protein 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34970,-0.104781847246798,0.114202729055627,-0.328619196195826,0.11905550170223,0.358911566752996
LYZL2,Lysozyme-like protein 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34971,0.041874991191401,0.0663964304910584,-0.0882620125710735,0.172011994953876,0.528271513720406
LYZL2,Lysozyme-like protein 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34970,-0.10191009916557,0.0663021130847239,-0.231862240811629,0.0280420424804885,0.124329129221029
LYZL2,Lysozyme-like protein 2,Working and living environment,X21100.Water hardness (USGS classification),48191,0.00935907281886864,0.0363179699722551,-0.0618241483267514,0.0805422939644887,0.796642599092114
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2139.Age first had sexual intercourse,45832,0.0022828202159154,0.00275985414384388,-0.0031264939060186,0.0076921343378494,0.40816209219734
LYZL2,Lysozyme-like protein 2,Health and medical history,X2149.Lifetime number of sexual partners,44414,-0.0241405079753476,0.0415532904378857,-0.105584957233603,0.0573039412829083,0.561280422502894
LYZL2,Lysozyme-like protein 2,Physical activities,X22032.IPAQ activity group,45142,-0.0532183803327354,0.0391896353692769,-0.130030065656518,0.0235933049910473,0.174491473928682
LYZL2,Lysozyme-like protein 2,Physical activities,X22033.Summed days activity,45466,-0.00387986482940632,0.00275849864513233,-0.00928652217386568,0.00152679251505304,0.159590204281089
LYZL2,Lysozyme-like protein 2,Physical activities,X22034.Summed minutes activity,45142,-0.00101893196307725,0.00278762046151326,-0.00648266806764324,0.00444480414148874,0.714727704313392
LYZL2,Lysozyme-like protein 2,Physical activities,X22037.MET minutes per week for walking,44548,-0.00233045189859166,0.00285530943445758,-0.00792685839012851,0.00326595459294519,0.414408293855342
LYZL2,Lysozyme-like protein 2,Physical activities,X22038.MET minutes per week for moderate activity,45142,-0.00154240192848596,0.00283200146018375,-0.00709312479044611,0.0040083209334742,0.586013179423541
LYZL2,Lysozyme-like protein 2,Physical activities,X22039.MET minutes per week for vigorous activity,45142,-0.0388178482659392,0.0391188866314219,-0.115490866063526,0.0378551695316477,0.321063511347369
LYZL2,Lysozyme-like protein 2,Physical activities,X22040.Summed MET minutes per week for all activity,44548,-0.00436368365943165,0.00282222262865448,-0.00989524001159443,0.00116787269273113,0.122079278243231
LYZL2,Lysozyme-like protein 2,Eye measures,X2217.Age started wearing glasses or contact lenses,45211,0.00500869142762417,0.00289446103707069,-0.00066445220503438,0.0106818350602827,0.0835702479761086
LYZL2,Lysozyme-like protein 2,Working and living environment,X22501.Year ended full time education,33168,-0.00123413564188836,0.012551665471406,-0.0258353999658441,0.0233671286820674,0.921678975586966
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X22506.Tobacco smoking,33135,0.289949835184268,0.151111276259171,-0.00622826628370776,0.586127936652243,0.0550744594622563
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,47179,0.0244891143806104,0.113073195622352,-0.197134349039199,0.24611257780042,0.828539969947293
LYZL2,Lysozyme-like protein 2,Physical measures,X23098.Weight,47957,-0.0122038317156679,0.00682647119152472,-0.0255837152510563,0.00117605181972056,0.0738365325660657
LYZL2,Lysozyme-like protein 2,Physical measures,X23099.Body fat percentage,47927,0.00065894874772967,0.0060907632643429,-0.0112789472503824,0.0125968447458418,0.913847523747136
LYZL2,Lysozyme-like protein 2,Physical measures,X23100.Whole body fat mass,47890,-0.00443050468924334,0.00608865167892304,-0.0163642619799325,0.00750325260144581,0.466826912265428
LYZL2,Lysozyme-like protein 2,Physical measures,X23101.Whole body fat-free mass,47952,-0.0114121609972494,0.00589698517889796,-0.0229702519478894,0.00014592995339056,0.0529737508487993
LYZL2,Lysozyme-like protein 2,Physical measures,X23102.Whole body water mass,47957,-0.0118578885886431,0.00588013710722392,-0.023382957318802,-0.000332819858484263,0.0437509827631412
LYZL2,Lysozyme-like protein 2,Physical measures,X23104.Body mass index (BMI),47957,0.0337778389909976,0.0138318998852253,0.00666731521595594,0.0608883627660392,0.0146140398096768
LYZL2,Lysozyme-like protein 2,Physical measures,X23105.Basal metabolic rate,47957,-0.01201968677776,0.00612349029253601,-0.0240217277511306,-1.76458043894146e-05,0.0496742253029326
LYZL2,Lysozyme-like protein 2,Physical measures,X23106.Impedance of whole body,47957,-0.00416863193376272,0.00481659980389683,-0.0136091675494005,0.00527190368187507,0.386790541459992
LYZL2,Lysozyme-like protein 2,Physical measures,X23107.Impedance of leg (right),47957,0.000550172229399805,0.00390989786012771,-0.00711322757645052,0.00821357203525012,0.888098387092554
LYZL2,Lysozyme-like protein 2,Physical measures,X23108.Impedance of leg (left),47957,-0.000161045694986584,0.00388564665235375,-0.00777691313359993,0.00745482174362677,0.966940526164272
LYZL2,Lysozyme-like protein 2,Physical measures,X23109.Impedance of arm (right),47957,-0.0088651138922724,0.00477422081983285,-0.0182225866991448,0.000492358914599993,0.063344638568595
LYZL2,Lysozyme-like protein 2,Physical measures,X23110.Impedance of arm (left),47957,-0.00753952567328326,0.00476442706383452,-0.0168778027183989,0.0017987513718324,0.11356043521996
LYZL2,Lysozyme-like protein 2,Physical measures,X23111.Leg fat percentage (right),47957,0.00841441516030893,0.00620905857413087,-0.00375533964498759,0.0205841699656054,0.175374840341774
LYZL2,Lysozyme-like protein 2,Physical measures,X23112.Leg fat mass (right),47957,-0.00235762297218915,0.00668366677229727,-0.0154576098458918,0.0107423639015135,0.724284253079261
LYZL2,Lysozyme-like protein 2,Physical measures,X23113.Leg fat-free mass (right),47956,-0.0153114669693084,0.00648189126829014,-0.0280159738551571,-0.00260696008345977,0.0181771056871159
LYZL2,Lysozyme-like protein 2,Physical measures,X23114.Leg predicted mass (right),47956,-0.0152443746563688,0.00652918940779448,-0.028041585895646,-0.00244716341709161,0.0195638539021521
LYZL2,Lysozyme-like protein 2,Physical measures,X23115.Leg fat percentage (left),47956,0.00699358351645883,0.00647877978666356,-0.00570482486540174,0.0196919918983194,0.280396174414339
LYZL2,Lysozyme-like protein 2,Physical measures,X23116.Leg fat mass (left),47956,-0.00380614659518521,0.0070673922017768,-0.0176582353106677,0.0100459421202973,0.590203342408564
LYZL2,Lysozyme-like protein 2,Physical measures,X23117.Leg fat-free mass (left),47955,-0.0161601489715526,0.0070402018939069,-0.0299589446836101,-0.00236135325949506,0.0217202882526043
LYZL2,Lysozyme-like protein 2,Physical measures,X23118.Leg predicted mass (left),47955,-0.0172147442105318,0.00709566489992204,-0.0311222474143791,-0.00330724100668464,0.0152714270268181
LYZL2,Lysozyme-like protein 2,Physical measures,X23119.Arm fat percentage (right),47955,-0.00577854986792809,0.00684284745352724,-0.0191905308768415,0.00763343114098531,0.398419667960948
LYZL2,Lysozyme-like protein 2,Physical measures,X23120.Arm fat mass (right),47954,-0.0142323710555607,0.00749457013349422,-0.0289217285172094,0.00045698640608796,0.0575761325708946
LYZL2,Lysozyme-like protein 2,Physical measures,X23121.Arm fat-free mass (right),47953,-0.00922298033784877,0.00645706639281955,-0.0218788304677751,0.00343286979207754,0.153205963874852
LYZL2,Lysozyme-like protein 2,Physical measures,X23122.Arm predicted mass (right),47953,-0.00927888359857165,0.00649221028028743,-0.022003615747935,0.00344584855079173,0.152953309236141
LYZL2,Lysozyme-like protein 2,Physical measures,X23123.Arm fat percentage (left),47951,-0.00488741140238005,0.00643636615694711,-0.0175026890699964,0.00772786626523629,0.447656482185775
LYZL2,Lysozyme-like protein 2,Physical measures,X23124.Arm fat mass (left),47951,-0.0107610667230366,0.00718686218481442,-0.0248473166052729,0.00332518315919963,0.134325084491298
LYZL2,Lysozyme-like protein 2,Physical measures,X23125.Arm fat-free mass (left),47947,-0.00730393336879913,0.00588137378508186,-0.0188314259875596,0.00422355924996132,0.214297595383861
LYZL2,Lysozyme-like protein 2,Physical measures,X23126.Arm predicted mass (left),47946,-0.00770512391279421,0.00591330761914769,-0.0192952068463237,0.00388495902073526,0.19258541539687
LYZL2,Lysozyme-like protein 2,Physical measures,X23127.Trunk fat percentage,47945,-0.000708349030762134,0.00515670452351684,-0.0108154898968551,0.00939879183533087,0.890743982715618
LYZL2,Lysozyme-like protein 2,Physical measures,X23128.Trunk fat mass,47945,-0.00490814635881936,0.00543888256848833,-0.0155683561930565,0.00575206347541777,0.366846017597689
LYZL2,Lysozyme-like protein 2,Physical measures,X23129.Trunk fat-free mass,47944,-0.00856185646367743,0.00511678420935224,-0.0185907535140078,0.00146704058665297,0.0942866732169581
LYZL2,Lysozyme-like protein 2,Physical measures,X23130.Trunk predicted mass,47942,-0.00820386864556673,0.00511739562859338,-0.0182339640776098,0.0018262267864763,0.108921499556525
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23400.Total Cholesterol,39560,-0.00251290849576536,0.00370608720929285,-0.00977683942597935,0.00475102243444863,0.497754979122443
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,39560,0.00213247955277221,0.00361673179926775,-0.00495631477379258,0.00922127387933699,0.555460903724266
LYZL2,Lysozyme-like protein 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",39560,0.00141846113447704,0.00363501654114305,-0.00570617128616334,0.00854309355511742,0.696380444208922
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23403.VLDL Cholesterol,39560,0.00981886113827227,0.00373382882773882,0.00250055663590418,0.0171371656406404,0.00855788535342667
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,39560,-0.000417443793709275,0.00360506667470263,-0.00748337447612643,0.00664848688870789,0.907818212330818
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23405.LDL Cholesterol,39560,0.00285071742622633,0.00358903614487297,-0.00418379341772469,0.00988522827017736,0.427046755972695
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23406.HDL Cholesterol,39560,-0.0174189081720029,0.0040894726787183,-0.0254342746222908,-0.00940354172171506,2.06640032781718e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23407.Total Triglycerides,39560,0.0217037941289889,0.00377484663096277,0.0143050947323019,0.0291024935256759,9.18538718365687e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23408.Triglycerides in VLDL,39560,0.0226690036623021,0.00382697610327571,0.0151681304998816,0.0301698768247225,3.2467576726924e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23409.Triglycerides in LDL,39560,0.0167528273104442,0.00357720342691574,0.00974150859368937,0.0237641460271991,2.85796779460392e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23410.Triglycerides in HDL,39560,0.0155106645615419,0.00369488035427627,0.00826869906716038,0.0227526300559233,2.71552282128249e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,39560,0.000155549638033198,0.00372176489890653,-0.0071391095638236,0.00745020883989,0.966663209112545
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23412.Phospholipids in VLDL,39560,0.0159715923004604,0.00376366307950757,0.0085948126646256,0.0233483719362953,2.21742848729428e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23413.Phospholipids in LDL,39560,0.00282968169053074,0.00360292689245292,-0.00423205501867699,0.00989141839973847,0.43224534556126
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23414.Phospholipids in HDL,39560,-0.00948972565908734,0.00390429349724194,-0.0171421409136815,-0.00183731040449314,0.0150903144995858
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23415.Total Esterified Cholesterol,39560,-0.00324656091871512,0.00372601286377861,-0.0105495461317212,0.00405642429429095,0.383596869708418
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,39560,0.00653728716921687,0.00371701668436968,-0.000748065532147698,0.0138226398705814,0.0786486122182471
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,39560,0.00473963066788519,0.00358853238600895,-0.00229389280869235,0.0117731541444627,0.186605200816948
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,39560,-0.0178626814262139,0.00408998273718891,-0.0258790475911042,-0.00984631526132363,1.26876290601865e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23419.Total Free Cholesterol,39560,-0.000663339196895637,0.00365973862148441,-0.00783642689500507,0.0065097485012138,0.856172220020774
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,39560,0.0138440128711533,0.00375225951424709,0.00648958422322901,0.0211984415190776,0.000225770920559032
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23421.Free Cholesterol in LDL,39560,-0.00217915787423371,0.00360507286043826,-0.0092451006806927,0.00488678493222529,0.545543816879501
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23422.Free Cholesterol in HDL,39560,-0.0148516658815451,0.00406385968754014,-0.0228168308691238,-0.00688650089396644,0.00025881524738221
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,39560,0.00541451341062592,0.00357625322601189,-0.00159494291235738,0.0124239697336092,0.130049992636953
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23424.Total Lipids in VLDL,39560,0.018438061767872,0.00376072007018809,0.0110670504303034,0.0258090731054407,9.58346359213901e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23425.Total Lipids in LDL,39560,0.003819962816103,0.00359153599338657,-0.00321944773093467,0.0108593733631407,0.287532727465103
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23426.Total Lipids in HDL,39560,-0.0115223905020138,0.00397416927494356,-0.0193117622809031,-0.0037330187231244,0.00374714792411585
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,39560,-0.00278840675502736,0.00378565425959885,-0.0102082891038411,0.00463147559378639,0.461398460945914
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23428.Concentration of VLDL Particles,39560,0.0131801061993238,0.0037202625259281,0.00588839164850469,0.0204718207501428,0.000397565133200459
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23429.Concentration of LDL Particles,39560,0.0043519693089086,0.00360403107324991,-0.00271193159466122,0.0114158702124784,0.227254832588277
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23430.Concentration of HDL Particles,39560,-0.00354257122685992,0.00378501689367759,-0.010961204338468,0.00387606188474817,0.349321639536658
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,39560,0.0254241426296265,0.0038785780160676,0.017822129718134,0.033026155541119,5.81349617368577e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,39560,-0.0102615695181941,0.003701769367971,-0.0175170374794173,-0.00300610155697094,0.00557947965229473
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,39560,-0.0252470510354933,0.00406298716979115,-0.033210505888284,-0.0172835961827027,5.35576265868763e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23434.Phosphoglycerides,39550,0.00139000468837211,0.00372600901042693,-0.00591297297206466,0.00869298234880889,0.709115050964319
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,39550,0.0250921743216868,0.00397569087494989,0.0172998202067851,0.0328845284365886,2.8721453222377e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23436.Total Cholines,39550,-0.000291279658597509,0.00379260065062644,-0.00772477693382532,0.00714221761663031,0.93878239079335
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23437.Phosphatidylcholines,39550,-0.00077552641129784,0.00380365150606534,-0.00823068336318591,0.00667963054059023,0.838443268099872
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23438.Sphingomyelins,39550,-0.00623313415399014,0.00383075692900941,-0.0137414177348486,0.00127514942686831,0.103738560685647
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23439.Apolipoprotein B,39560,0.00382020829039614,0.00361959603563673,-0.00327419993945186,0.0109146165202441,0.29125474534118
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23440.Apolipoprotein A1,39560,-0.00756562783789934,0.00389222938406629,-0.0151943974306693,6.31417548705932e-05,0.0519478500632804
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,39560,0.00746499326163997,0.00367602958113105,0.000259975282623125,0.0146700112406568,0.0423073188491337
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23442.Total Fatty Acids,39550,0.0122283279738629,0.00347426996236015,0.005418758847637,0.0190378971000888,0.000433817982999141
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23443.Degree of Unsaturation,39550,-0.0120692456347028,0.00373922897363393,-0.0193981344230253,-0.00474035684638026,0.00125141188579844
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,39550,0.00707621898174504,0.00364423525496917,-6.64821179945253e-05,0.0142189200814846,0.052192150822867
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,39550,0.00684788414254006,0.00359762907618865,-0.000203468846789701,0.0138992371318698,0.0570088768703435
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,39550,0.00736558511355346,0.00361429033666068,0.000281576053698531,0.0144495941734084,0.0415832860758973
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,39550,0.0170757760326445,0.00353090728594898,0.0101551977521845,0.0239963543131045,1.34222278398015e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23448.Saturated Fatty Acids,39550,0.0104367579452547,0.00342776495175979,0.00371833863980557,0.0171551772507039,0.00233410951374981
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23449.Linoleic Acid,39550,0.00722176878519281,0.00359124886050187,0.000182921018609143,0.0142606165517765,0.0443567649128786
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23450.Docosahexaenoic Acid,39550,-0.00217447606010314,0.00361831839100736,-0.00926638010647757,0.00491742798627129,0.547876961882665
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,39550,0.00087423550086719,0.00365228832339066,-0.0062842496129785,0.00803272061471288,0.810825878246409
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,39550,-0.0144541642557153,0.00356939327602241,-0.0214501750767193,-0.00745815343471143,5.16866196397999e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,39550,-0.014894242854009,0.00365559522057502,-0.022059209486336,-0.00772927622168191,4.6464717241598e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,39550,0.0233166973589439,0.003853163560091,0.0157644967811655,0.0308688979367222,1.48371307041887e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,39550,0.000159414304510977,0.00334078180365684,-0.00638851803065644,0.00670734663967839,0.961942126314696
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,39550,-0.00813042159315331,0.00365470631616502,-0.0152936459728367,-0.000967197213469871,0.0261254283286842
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,39550,-0.0097186992297257,0.00357266997356319,-0.0167211323779096,-0.00271626608154186,0.00653275914340663
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,39550,-0.0204570199684249,0.00380708692683373,-0.027918910345019,-0.0129951295918308,7.88479310892154e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,39550,-0.00502676560130859,0.0036047050811418,-0.0120919875603465,0.00203845635772933,0.16319459414762
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23460.Alanine,39557,0.0051089095662289,0.00360008620255205,-0.00194725939077313,0.0121650785232309,0.15589610409396
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23461.Glutamine,39523,-0.00185508182926379,0.00354051651017625,-0.00879449418920924,0.00508433053068166,0.600318406925685
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23462.Glycine,39547,0.0094069079484875,0.00428058768718258,0.00101695608160964,0.0177968598153654,0.0280003515670976
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23463.Histidine,39546,0.00899052709688982,0.00356166124879776,0.00200967104924621,0.0159713831445334,0.0116085318283437
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),39550,0.00732308593839064,0.00399577030842294,-0.000508623866118331,0.0151547957428996,0.0668729314929856
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23465.Isoleucine,39558,0.00258190915456181,0.00385608218940268,-0.00497601193666745,0.0101398302457911,0.503147340433311
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23466.Leucine,39558,0.0083561701272467,0.0039460226928326,0.000621965649294801,0.0160903746051986,0.0342298606899454
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23467.Valine,39550,0.00748801157566902,0.00398196058743087,-0.000316631175695478,0.0152926543270335,0.0600687186539516
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23468.Phenylalanine,39553,0.00554936191968695,0.00364978173505592,-0.00160421028102265,0.0127029341203965,0.128423252753326
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23469.Tyrosine,39548,9.07822442901469e-05,0.00380817321368593,-0.00737323725453427,0.00755480174311457,0.980981632765778
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23470.Glucose,39542,-0.00689091351545286,0.00347329758099243,-0.013698576774198,-8.32502567077072e-05,0.0472842808907047
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23471.Lactate,39545,0.0213472480936345,0.00365444045732694,0.0141845447972737,0.0285099513899953,5.32205325124694e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23472.Pyruvate,39520,0.00278783590079825,0.00350906653684261,-0.00408993451141326,0.00966560631300976,0.426941153787717
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23473.Citrate,39558,0.00568834622104481,0.00361671004826579,-0.00140040547355614,0.0127770979156458,0.115794988575158
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23474.3-Hydroxybutyrate,39332,0.00215133810896457,0.00403279836819362,-0.00575294669269492,0.0100556229106241,0.593725984645445
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23475.Acetate,39549,-0.0131760491387852,0.00343195388534361,-0.0199026787540587,-0.00644941952351178,0.000124117287126253
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23476.Acetoacetate,39559,-0.00601806755551235,0.00365237095364784,-0.0131767146246621,0.00114057951363743,0.0994397717212788
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23477.Acetone,39559,-0.00727193892782613,0.00360819655312288,-0.014344004171947,-0.000199873683705286,0.04388771250369
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23478.Creatinine,39356,0.0188275196175183,0.00447168549407687,0.0100630160491276,0.027592023185909,2.57009673488146e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23479.Albumin,39558,0.0112811031728971,0.00359816142391689,0.00422870678202001,0.0183334995637742,0.0017216678492593
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23480.Glycoprotein Acetyls,39560,0.0166459490662549,0.00375036935526561,0.00929522512993429,0.0239966730025755,9.14805370985448e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,39560,0.0171047489543137,0.00379965856257803,0.00965741817166072,0.0245520797369666,6.81221967032802e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,39560,0.0159232585131493,0.00377601450931812,0.00852227007488575,0.0233242469514128,2.49619632653588e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,39560,0.0179909733773944,0.00390423677207813,0.0103386693041213,0.0256432774506676,4.11022469934788e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,39560,0.0185424268278338,0.00383973119769262,0.0110165536803563,0.0260682999753114,1.39009802427743e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,39560,0.0189291456405138,0.0038374236823007,0.0114077952232044,0.0264504960578231,8.22601249839632e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,39560,0.0172894754996104,0.00381457790322432,0.00981290280929075,0.0247660481899301,5.89142063702016e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,39560,0.0141281158754365,0.00370332998606893,0.00686958910274139,0.0213866426481316,0.000136943953417552
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,39560,0.0229746376644186,0.00394842459562075,0.0152357254570019,0.0307135498718352,6.09733968485385e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,39560,0.0223482404145989,0.00392223774336905,0.0146606544375955,0.0300358263916022,1.24471014444635e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,39560,0.0205137892484412,0.00392135175340865,0.0128279398117603,0.0281996386851222,1.71422857450013e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,39560,0.0191186812054542,0.00390339567020316,0.011468025691856,0.0267693367190524,9.82194593177584e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,39560,0.0176046158442236,0.00390330182075175,0.00995414427555019,0.0252550874128971,6.54439795548069e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,39560,0.0198409382199087,0.00389187326388828,0.0122128666226876,0.0274690098171297,3.48909519424693e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,39560,0.0234856096880034,0.00393039175683973,0.0157820418445976,0.0311891775314093,2.36683841493836e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,39560,0.0230408889850987,0.00388964036005719,0.0154171938793867,0.0306645840908108,3.24324110092593e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,39560,0.0228823001193259,0.00387655316650053,0.0152842559129849,0.030480344325667,3.6809882193267e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,39560,0.0233009002859159,0.00395536181035299,0.015548391137624,0.0310534094342077,3.9523323921907e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,39560,0.0204025994314374,0.0039134743245029,0.0127321897554117,0.0280730091074631,1.8876235555717e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,39560,0.0173599532328994,0.00388815806474446,0.00973916342600025,0.0249807430397985,8.093445075813e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,39560,0.0229732245208322,0.00394506965324704,0.015240888000468,0.0307055610411964,5.93264915933903e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,39560,0.0232780103537403,0.00381508421985194,0.0158004452828305,0.0307555754246501,1.08578206596215e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,39560,0.0117978149065656,0.00368837957629644,0.00456859093702462,0.0190270388761067,0.00138468087860256
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,39560,0.0155285056635915,0.00369266046300811,0.00829089115609563,0.0227661201710874,2.62883638139551e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,39560,0.0106222163649135,0.00368222150232523,0.00340506222035609,0.017839370509471,0.00392512543205355
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,39560,0.000618207246682859,0.00362121530881582,-0.00647937475859614,0.00771578925196186,0.86444852716292
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,39560,-0.00449128986737035,0.00360787982888162,-0.0115627343319783,0.00258015459723763,0.213211404196136
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,39560,0.0072104419360646,0.00366366927939669,2.96501484470975e-05,0.0143912337236821,0.0490825048535977
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,39560,0.0235896325360418,0.00377647086260556,0.0161877496453349,0.0309915154267487,4.35382153323394e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,39560,0.0185234322820391,0.00379793075290994,0.0110794880063356,0.0259673765577426,1.09090549421341e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,39560,0.0178012042730658,0.0038035339510317,0.0103462777290437,0.025256130817088,2.90064743591792e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,39560,0.0120689090989923,0.00373810515318041,0.00474222299875871,0.0193955951992259,0.00124756669720208
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,39560,0.00947259489784787,0.00377219586017156,0.00207909101191161,0.0168660987837841,0.0120477153708
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,39560,0.0108578910538691,0.00383677824503961,0.00333780569359143,0.0183779764141467,0.00466399160437406
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,39560,0.00696410054830797,0.00367218947193681,-0.000233390816688168,0.0141615919133041,0.0579276704723358
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,39560,0.0240064752040976,0.00382639974388118,0.0165067317060904,0.0315062187021047,3.65382218481141e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,39560,0.00114440097693564,0.00365159133801394,-0.00601271804557168,0.00830151999944296,0.753984359907961
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,39560,0.00150541544341082,0.00367277222758809,-0.00569321812266183,0.00870404900948347,0.681898080892814
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,39560,0.00229158790446367,0.00365665450110095,-0.00487545491769419,0.00945863072662152,0.530875675140318
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,39560,-0.00648287064605116,0.00369931900202963,-0.0137335358900292,0.000767794597926908,0.079724464670752
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,39560,-0.00861730213525507,0.00372549138709405,-0.0159192652539594,-0.00131533901655074,0.0207375102775294
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,39560,-0.00132799019676859,0.00366407757124128,-0.0085095822364015,0.00585360184286431,0.71703392748763
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,39560,0.0177482480140849,0.00372328728325216,0.0104506049389107,0.0250458910892591,1.8956159006963e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23523.Concentration of IDL Particles,39560,-0.00408269397175539,0.00362845531915325,-0.0111944663972958,0.00302907845378499,0.260534064809513
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23524.Total Lipids in IDL,39560,-0.00609419146635815,0.00371020190361946,-0.0133661871974523,0.00117780426473598,0.100504797838564
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23525.Phospholipids in IDL,39560,-0.00639929837946133,0.00370480375598093,-0.013660713741184,0.000862116982261298,0.0841424156496644
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23526.Cholesterol in IDL,39560,-0.00800430568979215,0.00372711491263525,-0.0153094509185572,-0.000699160461027062,0.0317683941485297
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,39560,-0.00736394731559766,0.00373394952566206,-0.0146824883858953,-4.54062453000281e-05,0.0486164029966768
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23528.Free Cholesterol in IDL,39560,-0.00956485725935179,0.00369388465323044,-0.0168048711796835,-0.00232484333902012,0.00962770868521922
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23529.Triglycerides in IDL,39560,0.013783490277655,0.00360568914133068,0.00671633956064686,0.0208506409946631,0.00013272541351868
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,39560,0.00293565225186991,0.00358691015338074,-0.00409469164875635,0.00996599615249617,0.41312672603417
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23531.Total Lipids in Large LDL,39560,0.00116798049691644,0.00360981874431666,-0.00590726424194421,0.00824322523577709,0.74627996161689
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23532.Phospholipids in Large LDL,39560,-0.000436508834826876,0.00362009699469972,-0.00753189894443833,0.00665888127478458,0.904026459657261
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23533.Cholesterol in Large LDL,39560,0.000425829397331828,0.00360970860703515,-0.00664919947245707,0.00750085826712072,0.906095330189729
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,39560,0.00208827148264585,0.00360390716834978,-0.00497538656731971,0.00915192953261141,0.562299829039516
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,39560,-0.00407671713510802,0.00363905536072133,-0.0112092656421218,0.00305583137190578,0.262624137574715
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23536.Triglycerides in Large LDL,39560,0.0149191746420417,0.00357318946325489,0.0079157232940621,0.0219226259900213,2.99881683166843e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,39560,0.00629102293199443,0.00362683754908767,-0.000817578664217396,0.0133996245282063,0.0828441670655487
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,39560,0.00854384487450463,0.00360443624262601,0.00147914983895766,0.0156085399100516,0.0177875322676866
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,39560,0.0084348328447234,0.00361700661454439,0.00134549988021641,0.0155241658092304,0.0197190969558716
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,39560,0.00742888821830486,0.00359809969075488,0.000376612824425295,0.0144811636121844,0.0389777113277011
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,39560,0.00948856674935583,0.00361121855617143,0.00241057837925983,0.0165665551194518,0.00861283331259535
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,39560,0.00159530776964784,0.00357766355467578,-0.00541691279751669,0.00860752833681236,0.655672719628784
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,39560,0.0190487876236304,0.00359540998288487,0.012001784057176,0.0260957911900847,1.19292416961404e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,39560,0.00659923499630197,0.00362853122663692,-0.000512686207906391,0.0137111562005103,0.0689834281137245
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23545.Total Lipids in Small LDL,39560,0.00689765523400774,0.00357982434843681,-0.000118800488928395,0.0139141109569439,0.0540286519698648
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23546.Phospholipids in Small LDL,39560,0.00408244281803572,0.00356754418342359,-0.00290994378147451,0.011074829417546,0.252512379744689
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23547.Cholesterol in Small LDL,39560,0.00609618915519397,0.00358796652918721,-0.000936225242012965,0.0131286035524009,0.0893352745432126
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,39560,0.008493044918918,0.00359163785197786,0.00145343472904139,0.0155326551087946,0.0180633784779603
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,39560,-0.000321739811458276,0.00357902977891519,-0.00733663817813204,0.00669315855521549,0.928371646691824
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23550.Triglycerides in Small LDL,39560,0.0202742690947581,0.00363082446218117,0.013157853148883,0.0273906850406332,2.40743725392886e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,39560,-0.0221733501962947,0.0041344425322937,-0.0302768575595904,-0.0140698428329991,8.3477933988644e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,39560,-0.0249741117329907,0.0041429252103981,-0.033094245145371,-0.0168539783206104,1.71203089062601e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,39560,-0.0247093505107099,0.00411840512592017,-0.0327814245575134,-0.0166372764639063,2.03882277308651e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,39560,-0.0269723400875802,0.00419757272712515,-0.0351995826327455,-0.0187450975424149,1.36710680275516e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,39560,-0.0269288237737114,0.00422426796223322,-0.0352083889796886,-0.0186492585677343,1.90577369835489e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,39560,-0.0250769115858254,0.00406854207414118,-0.0330512540511421,-0.0171025691205087,7.36044419157705e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,39560,0.00955741867571565,0.00345888418542145,0.0027780056722896,0.0163368316791417,0.00573418037800471
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,39560,-0.0244775406842995,0.0041879048502317,-0.0326858341907536,-0.0162692471778454,5.21576803454963e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23559.Total Lipids in Large HDL,39560,-0.0239274400235456,0.0041495136596529,-0.0320604867964653,-0.0157943932506259,8.32086301172282e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23560.Phospholipids in Large HDL,39560,-0.0221200622027501,0.0041043645238394,-0.0301646166694753,-0.0140755077360248,7.21585771278779e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23561.Cholesterol in Large HDL,39560,-0.0269950700023481,0.00421623737856096,-0.0352588952643276,-0.0187312447403686,1.58953877813659e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,39560,-0.0274307064155068,0.00423182094158823,-0.0357250754610197,-0.0191363373699939,9.43965262228099e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,39560,-0.0249670206254274,0.00416058067178946,-0.0331217587421347,-0.01681228250872,2.02494896619032e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23564.Triglycerides in Large HDL,39560,0.00431431706358821,0.00362838453204071,-0.00279731661921159,0.011425950746388,0.234447223612135
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,39560,-0.00727986883083954,0.00384478340369443,-0.0148156443020806,0.000255906640401549,0.0583256199660709
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,39560,-0.00523301509089275,0.00377904027612935,-0.0126399340321063,0.00217390385032077,0.166157997005586
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,39560,-0.00325036118466018,0.00371229315146111,-0.010526455761524,0.00402573339220359,0.381284687885264
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,39560,-0.0100703273258563,0.00389016673953453,-0.017695054135344,-0.00244560051636863,0.00964768342551792
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,39560,-0.010310361913202,0.00388306529996331,-0.0179211699011301,-0.00269955392527392,0.00793731609515162
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,39560,-0.00882133001343354,0.00391042933763466,-0.0164857715151975,-0.00115688851166961,0.0240998498374635
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,39560,0.0149127144090776,0.00373407146697398,0.00759393433380862,0.0222314944843466,6.5478422382572e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,39560,0.0089738179166536,0.00360127161392774,0.00191532555335523,0.016032310279952,0.0127227399229241
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23573.Total Lipids in Small HDL,39560,0.0110743038640045,0.00360211351403713,0.00401416137649175,0.0181344463515173,0.00211451720786596
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23574.Phospholipids in Small HDL,39560,0.0099554117023127,0.00358326605310712,0.00293221023822275,0.0169786131664026,0.00547360002366145
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23575.Cholesterol in Small HDL,39560,0.00720534041479117,0.0035825671598709,0.000183508781444194,0.0142271720481381,0.0443263755563758
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,39560,0.00649479140651852,0.00359457900292315,-0.000550583439210849,0.0135401662522479,0.070816280138951
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,39560,0.00801366004725041,0.00358305742683231,0.000990867490659086,0.0150364526038417,0.0253362952578307
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23578.Triglycerides in Small HDL,39560,0.0252105164182926,0.00401845698640682,0.0173343407249352,0.0330866921116499,3.65911243017358e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39241,0.0057109228324018,0.00404130068211543,-0.00221002650454444,0.013631872169348,0.157643872811153
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39241,-0.00200423420735981,0.00388052672469251,-0.00961006658775712,0.0056015981730375,0.605526380499327
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39241,0.00159573855103669,0.00393018647724169,-0.00610742694435703,0.00929890404643041,0.684735277235928
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39241,-0.00756400888073918,0.00386686650970489,-0.0151430672397608,1.5049478282402e-05,0.050478545944399
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39241,-0.000280101420524627,0.00393299101593233,-0.00798876381175198,0.00742856097070273,0.943225257050669
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39500,-0.00735671368044338,0.00394853362902028,-0.0150958395933231,0.000382412232436371,0.0624679249669378
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39500,-0.0195950521280915,0.00399571241415711,-0.0274266484598394,-0.0117634557963436,9.52503795897187e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39500,-0.0182525588331549,0.0039761177589985,-0.026045749640792,-0.0104593680255179,4.47028097428787e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39500,-0.0210984568638767,0.00399758481621384,-0.0289337231036558,-0.0132631906240976,1.33254487167523e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39500,0.0185546736049775,0.00398733095964601,0.0107395049240713,0.0263698422858836,3.30342728863278e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,39560,0.0150364453864718,0.00413926477864652,0.00692348642032456,0.0231494043526189,0.000281821029684166
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,39560,-0.0149083420742316,0.00385645228034475,-0.0224669885437073,-0.00734969560475587,0.000111356728124065
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,39560,-0.0190530596502123,0.00391852225120651,-0.026733363262577,-0.0113727560378475,1.17636548778167e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,39560,-0.00168802878245546,0.00391535951969804,-0.00936213344106362,0.00598607587615269,0.666382358433577
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,39560,0.00679299141881836,0.00393674222307388,-0.000923023338406445,0.0145090061760432,0.0844590636437939
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,39560,-0.0195171264864201,0.00379602629293977,-0.026957338020582,-0.0120769149522581,2.77310171195255e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,39560,-0.0247249653741428,0.00392416908585593,-0.0324163367824204,-0.0170335939658652,3.07696853559743e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,39560,-0.0252635026659018,0.00394495760465945,-0.0329956195710344,-0.0175313857607693,1.57555250631091e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,39560,-0.0226729075960293,0.00384156170233633,-0.0302023685326085,-0.0151434466594501,3.69751248114344e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,39560,0.0237733312389134,0.00389148093874262,0.0161460285989778,0.0314006338788489,1.03614645523438e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,39560,-0.0190264025464854,0.00383461345971735,-0.0265422449275314,-0.0115105601654394,7.09093733580155e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,39560,-0.0174706798387137,0.00370323225610776,-0.0247290150606849,-0.0102123446167425,2.4149228531732e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,39560,-0.0149373041539987,0.00364396754819386,-0.0220794805484587,-0.00779512775953875,4.17593581527537e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,39560,-0.0197024627075732,0.00386860475083816,-0.027284928019216,-0.0121199973959304,3.58467148803066e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,39560,0.0181292751879395,0.00374052625206677,0.0107978437338886,0.0254607066419904,1.27242385342828e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,39560,0.00680237399738537,0.00363678021721842,-0.000325715228362738,0.0139304632231335,0.0614495711919918
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,39560,-0.0233848108365444,0.00382094810102972,-0.0308738691145627,-0.0158957525585262,9.66778496132883e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,39560,-0.0236453895906014,0.00387109022351885,-0.0312327264286983,-0.0160580527525045,1.0417989611578e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,39560,-0.015386406944817,0.00338047544828401,-0.0220121388234536,-0.00876067506618033,5.38249786322029e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,39560,0.0243328381371967,0.00377005310970719,0.0169435340421706,0.0317221422322228,1.13354108228663e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,39560,-0.000720172962652884,0.00357181552690529,-0.00772093139538725,0.00628058547008149,0.840212403045984
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,39560,-0.0160558014890598,0.00372133473583833,-0.0233496175713029,-0.00876198540681663,1.6134665072312e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,39560,-0.010475481259619,0.00369068261276203,-0.0177092191806325,-0.00324174333860538,0.00454295312278454
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,39560,-0.0155656265911537,0.00341383573327904,-0.0222567446283806,-0.00887450855392675,5.18136376141226e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,39560,0.0191853371702482,0.00373929618341314,0.0118563166507584,0.0265143576897379,2.93550970120889e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,39560,-0.0113663712027099,0.00362341421981659,-0.0184682630735504,-0.0042644793318694,0.00171183000822082
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,39560,-0.00798630066651174,0.00370028350119497,-0.0152388563288539,-0.000733745004169604,0.0309266060522265
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,39560,0.00960986988924124,0.00352221048017242,0.00270633734810329,0.0165134024303792,0.00637509077912667
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,39560,-0.0264749242889949,0.00395862774895614,-0.034233834676949,-0.0187160139010409,2.37408258163697e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,39560,0.0135900754179656,0.00363654093312233,0.00646245518904588,0.0207176956468854,0.000187109200825624
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,39560,-0.00409740918379296,0.00372297353510322,-0.0113944373125953,0.00319961894500934,0.2711061246219
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,39560,-0.00934989054516223,0.00367955079365641,-0.0165618101007288,-0.00213797098959567,0.0110659524691417
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,39560,0.0126710043762379,0.00372003425410449,0.00537973723819314,0.0199622715142827,0.000661218965649176
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,39560,-0.021996133429759,0.00382177350650222,-0.0294868095025033,-0.0145054573570146,8.87144192953548e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,39560,0.0125117785877901,0.0036255883629399,0.00540562539642785,0.0196179317791523,0.000560691597794988
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,39560,-0.0146570055644642,0.00371666563406688,-0.0219416702072352,-0.00737234092169309,8.07705295103247e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,39560,-0.00261681966467709,0.00361151599027448,-0.00969539100561507,0.00446175167626089,0.468727339075773
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,39560,0.0132309650420029,0.00368364486226448,0.00601102111196449,0.0204509089720413,0.00032982243462574
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,39560,-0.015792364939636,0.00363541171825458,-0.0229177719074149,-0.00866695797185699,1.41146302760433e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,39560,0.0182142953285753,0.00370265671562218,0.0109570881659559,0.0254715024911948,8.81384428260821e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,39550,-0.0202601724090604,0.00392249438227195,-0.0279482613983134,-0.0125720834198074,2.44501735306115e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,39550,0.00537246109908312,0.00340932402590543,-0.00130981399169153,0.0120547361898578,0.115097525003734
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,39550,-0.00190952395512603,0.00318902484779959,-0.00816001265681322,0.00434096474656117,0.549332059096676
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,39550,0.017433513508902,0.00407880334674165,0.0094390589492884,0.0254279680685157,1.93471438241912e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,39550,0.027094949559212,0.00385816622677767,0.0195329437547278,0.0346569553636963,2.30435018023768e-12
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,39560,0.0148210804405331,0.00365470593343275,0.00765785681100486,0.0219843040700613,5.04076218064767e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,39560,-0.0230360650088072,0.00385553036914174,-0.030592904532325,-0.0154792254852894,2.3751817561557e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,39560,-0.0194222161630657,0.00371144123874048,-0.026696640990997,-0.0121477913351344,1.69801806214191e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,39560,-0.0186727519395757,0.00367619797759188,-0.0258780999756558,-0.0114674039034956,3.8492841535739e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,39560,0.0226013207876639,0.00370540790734249,0.0153387212892726,0.0298639202860552,1.09955716167559e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,39560,0.0163281589332268,0.00395388463830562,0.0085785450421478,0.0240777728243058,3.66010790888462e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,39560,-0.0195623065610703,0.00393484567534742,-0.0272746040847513,-0.0118500090373894,6.74229138826194e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,39560,-0.0163880778398806,0.00373316704466282,-0.0237050852474197,-0.00907107043234144,1.14486500845435e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,39560,-0.0173449338986112,0.00412943055253692,-0.0254386177815836,-0.00925125001563885,2.68645709617362e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,39560,0.0202849302657118,0.00387292152163254,0.012694004083312,0.0278758564481116,1.6566713352735e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,39560,-0.00657601729992403,0.00357786202644006,-0.0135886268717466,0.000436592271898489,0.0660932888348311
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,39560,-0.00738845899278108,0.00355401917347425,-0.0143543365727906,-0.000422581412771546,0.0376495235739585
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,39560,-0.00584687071960541,0.00349616340165235,-0.012699350986844,0.00100560954763319,0.0944803816901928
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,39560,-0.00711858010774392,0.00382935316138511,-0.0146241123040587,0.000386952088570888,0.0630608594213646
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,39560,0.0225442796803717,0.00402500454600353,0.0146552707702048,0.0304332885905386,2.18184012112356e-08
LYZL2,Lysozyme-like protein 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,48131,-0.00187913738315903,0.00303490635612841,-0.00782755384117071,0.00406927907485265,0.53580846625703
LYZL2,Lysozyme-like protein 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,48131,-0.00157581902991952,0.0029581081342269,-0.00737371097300424,0.00422207291316519,0.594239175566253
LYZL2,Lysozyme-like protein 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,46763,-0.00103375299096221,0.00282525284169067,-0.00657124856067592,0.0045037425787515,0.714445812849859
LYZL2,Lysozyme-like protein 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,46763,-0.00132701314665753,0.00308095222785388,-0.00736567951325113,0.00471165321993607,0.666680531015289
LYZL2,Lysozyme-like protein 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,46763,-0.00406876801450053,0.00304557151993604,-0.0100380881935752,0.0019005521645741,0.181578411373506
LYZL2,Lysozyme-like protein 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,46763,-0.000639230863387524,0.00280217551472341,-0.00613149487224541,0.00485303314547036,0.81955591271653
LYZL2,Lysozyme-like protein 2,Working and living environment,X24009.Traffic intensity on the nearest road,48131,0.0435371948753372,0.0778122205655629,-0.108974757433166,0.196049147183841,0.575815921777498
LYZL2,Lysozyme-like protein 2,Working and living environment,X24010.Inverse distance to the nearest road,48131,0.00203041668831218,0.00266358707080896,-0.00319021397047338,0.00725104734709774,0.445898184921114
LYZL2,Lysozyme-like protein 2,Working and living environment,X24011.Traffic intensity on the nearest major road,48131,0.00210876266890476,0.00263615671236569,-0.003058104487332,0.00727562982514151,0.423756286094181
LYZL2,Lysozyme-like protein 2,Working and living environment,X24012.Inverse distance to the nearest major road,48131,-0.00304778646079439,0.00269777129683281,-0.00833541820258668,0.00223984528099791,0.258598684639921
LYZL2,Lysozyme-like protein 2,Working and living environment,X24013.Total traffic load on major roads,48131,0.011445198408136,0.0550391011400154,-0.0964314398262941,0.119321836642566,0.835272767897835
LYZL2,Lysozyme-like protein 2,Working and living environment,X24015.Sum of road length of major roads within 100m,48131,-0.0202654763538159,0.0539136996830456,-0.125936327732585,0.0854053750249534,0.707004746594792
LYZL2,Lysozyme-like protein 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,48131,-0.00314395370755532,0.00305077162043777,-0.00912346608361335,0.0028355586685027,0.302767574600805
LYZL2,Lysozyme-like protein 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,48131,-0.00367483257753934,0.00305079992066473,-0.0096544004220422,0.00230473526696353,0.228392736948018
LYZL2,Lysozyme-like protein 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,48131,-0.00320155806939079,0.0030126493005295,-0.00910635069842862,0.00270323455964704,0.287928802550218
LYZL2,Lysozyme-like protein 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,48094,-0.000581773201023325,0.00294166735096428,-0.00634744120891332,0.00518389480686667,0.843227174507509
LYZL2,Lysozyme-like protein 2,Working and living environment,X24020.Average daytime sound level of noise pollution,48131,0.00109329886316613,0.00264884247847072,-0.00409843239463648,0.00628503012096874,0.679797325283502
LYZL2,Lysozyme-like protein 2,Working and living environment,X24021.Average evening sound level of noise pollution,48131,0.00110520222415756,0.00264924826878864,-0.00408732438266816,0.00629772883098329,0.676554421497603
LYZL2,Lysozyme-like protein 2,Working and living environment,X24022.Average night-time sound level of noise pollution,48131,0.00108116599471602,0.00264880487395721,-0.00411049155824011,0.00627282354767216,0.683152428703372
LYZL2,Lysozyme-like protein 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,48131,0.00106322793408852,0.00264906661732275,-0.00412894263586407,0.00625539850404112,0.688159886911215
LYZL2,Lysozyme-like protein 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,48131,0.00106906894016681,0.00264915648690928,-0.00412327777417538,0.00626141565450901,0.686547566896126
LYZL2,Lysozyme-like protein 2,Health and medical history,X2405.Number of children fathered,48115,0.222656917816452,0.0422329009320958,0.139880431989544,0.305433403643359,1.36292654230512e-07
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",45891,0.00349211536393388,0.00314570799662837,-0.00267347230945773,0.00965770303732549,0.266962483412844
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",45891,-0.00267216471615723,0.00282523284570332,-0.00820962109373573,0.00286529166142128,0.344253080228495
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24502.Water percentage, buffer 1000m",45891,0.000930234531602026,0.00284916946485144,-0.0046541376195068,0.00651460668271085,0.744055164806686
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",45891,0.00154000479610753,0.00295022525983821,-0.00424243671317537,0.00732244630539042,0.601680035545211
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",45891,-0.00159193198080565,0.00285681379144984,-0.00719128701204735,0.00400742305043604,0.577370422264056
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24505.Water percentage, buffer 300m",45891,0.000297494500549687,0.00286875309701332,-0.00532526156959642,0.00592025057069579,0.917407300267347
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",48192,0.00136314142099174,0.00300204034296095,-0.00452085765121173,0.00724714049319521,0.649782285206898
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",48192,-0.000693843788170164,0.00281464898542112,-0.00621055579959556,0.00482286822325523,0.805288763658245
LYZL2,Lysozyme-like protein 2,Working and living environment,X24508.Distance (Euclidean) to coast,48192,0.0043697798182195,0.00266236405719193,-0.000848453733876682,0.00958801337031568,0.100747958129121
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2867.Age started smoking in former smokers,34399,0.000838494753854825,0.00465756949248751,-0.00829034145142069,0.00996733095913034,0.85713656780647
LYZL2,Lysozyme-like protein 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35487,-0.0588923684967598,0.0841587204730685,-0.223843460623974,0.106058723630454,0.484089988380711
LYZL2,Lysozyme-like protein 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35488,-0.0214411087359924,0.0954066196997552,-0.208438083347513,0.165555865875528,0.822192901729412
LYZL2,Lysozyme-like protein 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35488,-0.0673745653087717,0.0895377448194001,-0.242868545154796,0.108119414537252,0.451793524408686
LYZL2,Lysozyme-like protein 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35477,-0.0478823578596247,0.0898101883468331,-0.223910327019418,0.128145611300168,0.593946552149881
LYZL2,Lysozyme-like protein 2,Mental health,X28739.Difficulty with standing for long periods,35491,0.0492756416197651,0.0768111405127923,-0.101274193785308,0.199825477024838,0.521208276658738
LYZL2,Lysozyme-like protein 2,Mental health,X28740.Difficulty with taking care of household responsibilities,35506,0.0214103842900359,0.0892056543688159,-0.153432698272843,0.196253466852915,0.81032845604794
LYZL2,Lysozyme-like protein 2,Mental health,X28741.Difficulty learning a new task,35469,0.111672234658448,0.102811573213741,-0.0898384488404853,0.313182918157381,0.277435946765896
LYZL2,Lysozyme-like protein 2,Mental health,X28742.Difficulty with joining in community activities,35112,0.0224583654206039,0.0962633744601962,-0.166217848521381,0.211134579362588,0.815534825622079
LYZL2,Lysozyme-like protein 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,35464,-0.113397804569049,0.0860598594219082,-0.282075129035989,0.0552795198978913,0.187660824293896
LYZL2,Lysozyme-like protein 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35514,0.144930174811117,0.10956021909975,-0.0698078546243925,0.359668204246627,0.185933773315223
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,33909,-0.115868047845031,0.079281834263447,-0.271260443001387,0.0395243473113251,0.143945608582935
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2897.Age stopped smoking,34390,0.000465083345831479,0.00491245366710695,-0.00916332584169814,0.0100934925333611,0.924576770192122
LYZL2,Lysozyme-like protein 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34688,0.00532499631225355,0.0106521495991722,-0.015553216902124,0.0262032095266311,0.617164436672044
LYZL2,Lysozyme-like protein 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34688,-0.00955911566377549,0.0119755118667929,-0.0330311189226896,0.0139128875951386,0.42477287403206
LYZL2,Lysozyme-like protein 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34688,0.0658505133944069,0.0405497918670599,-0.0136270786650305,0.145328105453844,0.104439940036647
LYZL2,Lysozyme-like protein 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34688,-0.0207180419857848,0.0407883507941254,-0.100663209542271,0.059227125570701,0.611513701854109
LYZL2,Lysozyme-like protein 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34688,0.0367400309029385,0.0488208378775467,-0.058948811337053,0.13242887314293,0.451750585130356
LYZL2,Lysozyme-like protein 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34688,-0.0440012232140682,0.0448444667244078,-0.131896377993907,0.0438939315657709,0.326534955868055
LYZL2,Lysozyme-like protein 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34688,-0.024262237737332,0.0183148533746004,-0.0601593503515488,0.0116348748768848,0.185310404424966
LYZL2,Lysozyme-like protein 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34688,0.0152246736618797,0.0347207889504634,-0.0528280726810285,0.083277420004788,0.661047617577809
LYZL2,Lysozyme-like protein 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,34660,-0.0316676720011575,0.0891626240714573,-0.206426415181214,0.143091071178899,0.722476427274866
LYZL2,Lysozyme-like protein 2,Mental health,X29003.Recent feelings of depression,34662,0.0211709391243986,0.0878207194462628,-0.150957670990276,0.193299549239074,0.809509034392165
LYZL2,Lysozyme-like protein 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34663,0.0691270082679784,0.0687162086272312,-0.0655567606413947,0.203810777177352,0.314466212843602
LYZL2,Lysozyme-like protein 2,Mental health,X29005.Recent feelings of tiredness or low energy,34664,-0.00254836379905801,0.0684264537583477,-0.13666421316542,0.131567485567304,0.970292976230766
LYZL2,Lysozyme-like protein 2,Mental health,X29006.Recent poor appetite or overeating,34671,-0.0244658963567989,0.108631222091899,-0.237383091656921,0.188451298943323,0.821815911035497
LYZL2,Lysozyme-like protein 2,Mental health,X29007.Recent feelings of inadequacy,34653,-0.0427834273357764,0.0969419715086996,-0.232789691492828,0.147222836821275,0.658989677382254
LYZL2,Lysozyme-like protein 2,Mental health,X29008.Recent trouble concentrating on things,34669,0.00327997497546427,0.0927069919599438,-0.178425729266026,0.184985679216954,0.971777882582693
LYZL2,Lysozyme-like protein 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34665,-0.202010021523576,0.165925357039782,-0.527223721321549,0.123203678274397,0.223470815799103
LYZL2,Lysozyme-like protein 2,Mental health,X29010.Recent thoughts of suicide or self-harm,34649,-0.357586714587752,0.184118192545861,-0.718458371977641,0.00328494280213609,0.0521642879038501
LYZL2,Lysozyme-like protein 2,Mental health,X29038#0.Substances taken for depression_None of options listed,34739,0.0350784645250681,0.020577128351454,-0.00525270704378169,0.0754096360939179,0.0882952395726278
LYZL2,Lysozyme-like protein 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),34739,-0.00767467229063344,0.0369101064023512,-0.0800184808392417,0.0646691362579748,0.835291497735815
LYZL2,Lysozyme-like protein 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),34739,0.00355332040929792,0.0233470358936335,-0.0422068699422238,0.0493135107608196,0.879037521268683
LYZL2,Lysozyme-like protein 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),34739,0.0401636421259783,0.0708249831139504,-0.0986533247773645,0.178980609029321,0.570678543122018
LYZL2,Lysozyme-like protein 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),34739,-0.0385924534085354,0.0453818332356956,-0.127540846550499,0.0503559397334281,0.395139055684216
LYZL2,Lysozyme-like protein 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),34739,0.0208658706974308,0.0553855202236008,-0.0876897489408267,0.129421490335688,0.706380796240134
LYZL2,Lysozyme-like protein 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),34739,-0.00747857718668222,0.0554238697340454,-0.116109361865411,0.101152207492047,0.892668299022613
LYZL2,Lysozyme-like protein 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),34739,0.0197294381861207,0.0634016382847792,-0.104537772852046,0.143996649224288,0.755672956801139
LYZL2,Lysozyme-like protein 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),34739,0.0204004229090308,0.0452541254368309,-0.0682976629471577,0.109098508765219,0.652151801782869
LYZL2,Lysozyme-like protein 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,34739,0.0059802206570742,0.0194625406371956,-0.0321663589918292,0.0441268003059776,0.758649628447731
LYZL2,Lysozyme-like protein 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,34739,0.0336747602936956,0.0311191917497633,-0.0273188555358404,0.0946683761232316,0.279240849082083
LYZL2,Lysozyme-like protein 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,34739,-0.104153431424218,0.0506638978105242,-0.203454671132845,-0.00485219171559043,0.0398466779932365
LYZL2,Lysozyme-like protein 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,34739,0.0398439495828091,0.0594050752850411,-0.0765899979758715,0.15627789714149,0.502426537880267
LYZL2,Lysozyme-like protein 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,34739,0.0398794499042129,0.038370168912309,-0.0353260811639127,0.115084980972338,0.29869001079748
LYZL2,Lysozyme-like protein 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,34739,-0.0265230991598119,0.0554129963104389,-0.135132571928272,0.0820863736086482,0.632208944591086
LYZL2,Lysozyme-like protein 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,34739,-0.0685705777970061,0.0542945176361164,-0.174987832363794,0.0378466767697821,0.206659637959125
LYZL2,Lysozyme-like protein 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,34739,0.0124218271462292,0.0310414497447885,-0.0484194143535563,0.0732630686460146,0.689045939780872
LYZL2,Lysozyme-like protein 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,34739,0.00550363056581721,0.0306603541611901,-0.0545906635901153,0.0655979247217498,0.85754855765279
LYZL2,Lysozyme-like protein 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,34739,-0.0557466378052758,0.0456724382119846,-0.145264616700766,0.0337713410902139,0.222293843838058
LYZL2,Lysozyme-like protein 2,Mental health,X29058.Recent feelings or nervousness or anxiety,34569,-0.0815658725394746,0.0864492265218881,-0.251006356522375,0.0878746114434261,0.345457339339517
LYZL2,Lysozyme-like protein 2,Mental health,X29059.Recent inability to stop or control worrying,34572,0.0527703537054729,0.0899305823576818,-0.123493587715583,0.229034295126529,0.557367036340192
LYZL2,Lysozyme-like protein 2,Mental health,X29060.Recent worrying too much about different things,34572,-0.0241102816740245,0.0814817048084674,-0.183814423098621,0.135593859750572,0.767318193235945
LYZL2,Lysozyme-like protein 2,Mental health,X29061.Recent trouble relaxing,34569,0.0162388691862982,0.0864231722750399,-0.15315054847278,0.185628286845376,0.850961839011312
LYZL2,Lysozyme-like protein 2,Mental health,X29062.Recent restlessness,34576,0.00238603526037366,0.120123895690207,-0.233056800292433,0.23782887081318,0.984153229285514
LYZL2,Lysozyme-like protein 2,Mental health,X29063.Recent easy annoyance or irritability,34566,-0.0550585676881145,0.08394404826615,-0.219588902289768,0.10947176691354,0.511916326532578
LYZL2,Lysozyme-like protein 2,Mental health,X29064.Recent feelings of foreboding,34571,-0.171169746829726,0.106624789163849,-0.380154333590871,0.0378148399314184,0.108470440740554
LYZL2,Lysozyme-like protein 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,34739,0.00286491574615656,0.0242612448618978,-0.0446871241831632,0.0504169556754763,0.906003301612804
LYZL2,Lysozyme-like protein 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,34739,-0.00402241790901069,0.0365544347564215,-0.0756691100315969,0.0676242742135755,0.912381945169917
LYZL2,Lysozyme-like protein 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',34739,-0.0134882290434228,0.0516534814482372,-0.114729052681968,0.0877525945951221,0.794001682046912
LYZL2,Lysozyme-like protein 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,34739,-0.0173217837862041,0.0502427324844314,-0.11579753945569,0.0811539718832814,0.730285130527346
LYZL2,Lysozyme-like protein 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,34739,0.010578334874871,0.0317208110950979,-0.0515944548715209,0.0727511246212628,0.738781498525393
LYZL2,Lysozyme-like protein 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,34739,-0.0235313843385283,0.039796365407206,-0.101532260536652,0.0544694918595955,0.554344676642394
LYZL2,Lysozyme-like protein 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,34739,0.0434095714533392,0.0376254924681636,-0.0303363937842615,0.11715553669094,0.248656753541783
LYZL2,Lysozyme-like protein 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,34739,0.0301019961260833,0.0394204567795637,-0.0471620991618615,0.107366091414028,0.445126899038199
LYZL2,Lysozyme-like protein 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,34739,0.0333753254766197,0.0470580349364381,-0.058858422998799,0.125609073952038,0.478204007819578
LYZL2,Lysozyme-like protein 2,Mental health,X29076.Felt loved as a child,34545,0.112156511415379,0.0705292685115921,-0.026080854867341,0.2503938776981,0.11184015387478
LYZL2,Lysozyme-like protein 2,Mental health,X29077.Physically abused by family as a child,34554,-0.129717130421538,0.0906963110537301,-0.307481900086849,0.0480476392437733,0.152701792293081
LYZL2,Lysozyme-like protein 2,Mental health,X29078.Felt hated by family member as a child,34546,-0.0293620241382543,0.102472547477825,-0.230208217194792,0.171484168918283,0.774477984477954
LYZL2,Lysozyme-like protein 2,Mental health,X29079.Sexually molested as a child,34530,0.217500424225365,0.146676206785112,-0.0699849410734538,0.504985789524184,0.138164517214478
LYZL2,Lysozyme-like protein 2,Mental health,X29080.Someone to take to doctor when needed as a child,34542,0.0710852003689791,0.108153692634051,-0.140896037193761,0.28306643793172,0.511038601192324
LYZL2,Lysozyme-like protein 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34550,-0.29048003393592,0.163819107704543,-0.611565485036824,0.0306054171649843,0.0762507791261591
LYZL2,Lysozyme-like protein 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34535,-0.0329376314782036,0.131952458588632,-0.291564450311922,0.225689187355514,0.802891870519258
LYZL2,Lysozyme-like protein 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34560,-0.256619176823874,0.15375929252809,-0.55798739017893,0.0447490365311815,0.0951764615350538
LYZL2,Lysozyme-like protein 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34553,-0.724443892514422,0.515367604913506,-1.73456439814489,0.28567661311605,0.159870236462327
LYZL2,Lysozyme-like protein 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34546,0.34568176516195,0.257927310289412,-0.159855763005297,0.851219293329197,0.180221992292175
LYZL2,Lysozyme-like protein 2,Mental health,X29086.Experienced a violent or sexual assault,34564,-0.121470551291266,0.164878538798809,-0.444632487336931,0.201691384754399,0.461317072054457
LYZL2,Lysozyme-like protein 2,Mental health,X29087.Experienced a life-threatening injury or illness,34557,-0.183278045268812,0.0813124474112412,-0.342650442194845,-0.0239056483427789,0.0242325300726145
LYZL2,Lysozyme-like protein 2,Mental health,X29088.Experienced a marital separation or divorce,34557,-0.00699766349389473,0.0790303002278838,-0.161897051940547,0.147901724952757,0.929447245441531
LYZL2,Lysozyme-like protein 2,Mental health,X29089.Experienced the death of a spouse or partner,34568,-0.247733192251684,0.126306799302825,-0.49529451888522,-0.000171865618147748,0.0498833939456092
LYZL2,Lysozyme-like protein 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34559,-0.099869937636314,0.0986841795738349,-0.29329092960103,0.0935510543284024,0.311571649738024
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29091.Frequency of drinking alcohol,34553,-0.12911876180939,0.0639783849596117,-0.254516396330228,-0.00372112728855054,0.0436191558052361
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,34058,-0.183193613318301,0.0691814506644713,-0.318789256620665,-0.0475979700159372,0.00811986202681993
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,34077,-0.118612057691679,0.0683089240995549,-0.252497548926807,0.0152734335434485,0.0825482495495999
LYZL2,Lysozyme-like protein 2,Mental health,X29104.Ever used cannabis,34550,0.00581012306571759,0.0852071377304454,-0.161195866885955,0.172816113017391,0.945638096489811
LYZL2,Lysozyme-like protein 2,Mental health,X29108.Ever thought that life not worth living,34530,-0.0976959403313486,0.0872976825471323,-0.268799398123728,0.0734075174610306,0.263137422344774
LYZL2,Lysozyme-like protein 2,Mental health,X29109.Ever contemplated self-harm,34533,-0.0948469683228804,0.122908051229409,-0.335746748732521,0.14605281208676,0.440328532532229
LYZL2,Lysozyme-like protein 2,Mental health,X29111.Ever self-harmed,34545,-0.304719297512595,0.226814469944841,-0.749275658604484,0.139837063579294,0.179169890608379
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34547,0.000568375762718579,0.131236293455705,-0.256654759410463,0.2577915109359,0.996544570491776
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,35216,0.0573746863239358,0.0509259488296139,-0.0424401733821075,0.157189546029979,0.259939939186346
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,35216,0.016826363674122,0.0390447191833883,-0.0597012859253191,0.0933540132735631,0.666517985148863
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,35216,0.0422915139574496,0.0471874975863861,-0.0501959813118672,0.134779009226766,0.370155042094717
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,35216,-0.0426495924504511,0.0825939752548048,-0.204533783949869,0.119234599048966,0.605608694991492
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34535,-0.0834314267168291,0.0741627009432148,-0.22879032056553,0.0619274671318719,0.260643745043787
LYZL2,Lysozyme-like protein 2,Health and medical history,X29153.Pain or discomfort today,34547,0.140884554759379,0.0677569138460315,0.00808100362115696,0.273688105897601,0.0376358041130456
LYZL2,Lysozyme-like protein 2,Mental health,X29154.Anxiety or depression today,34547,-0.150132689681363,0.0917455940874102,-0.329954054092687,0.0296886747299611,0.101808385575451
LYZL2,Lysozyme-like protein 2,Mental health,X29166.Frequency of confiding in someone close,34400,0.109169128376821,0.0680408115320691,-0.0241908622260345,0.242529118979676,0.108665986596472
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34532,0.0199071656019444,0.0100365465981356,0.000235534269598599,0.0395787969342902,0.0473612478594979
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34532,-0.0190757608775156,0.0104110702306773,-0.0394814585296431,0.00132993677461183,0.0669631797958753
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34532,-0.0100080979686776,0.0110694082775749,-0.0317041381927245,0.0116879422553692,0.365967313229849
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34532,-0.00745618095908528,0.0151749899764321,-0.0371991613128922,0.0222867993947217,0.623199446877349
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34532,0.00744227853178613,0.0306892120294602,-0.0527085770459559,0.0675931341095282,0.808397489704408
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34532,-0.0137236241310703,0.0111660213788509,-0.035609026033618,0.00816177777147744,0.219100953238934
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34526,-0.0147164623345409,0.0117278174547035,-0.0377029845457598,0.00827005987667809,0.209588566549913
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34526,0.00484899778476357,0.018515576690124,-0.0314415325278794,0.0411395280974065,0.793417291723737
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34526,0.00692098854582154,0.0210234864571128,-0.0342850449101196,0.0481270220017627,0.742014114704918
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34526,0.0130526723096508,0.0257709306679865,-0.0374583517996027,0.0635636964189043,0.612532813438796
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34526,0.0684016476777822,0.0441957065531158,-0.0182219371663248,0.155025232521889,0.121748198974419
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34526,0.0231820737661064,0.0168067323212038,-0.00975912158345305,0.0561232691156659,0.167844279398786
LYZL2,Lysozyme-like protein 2,Mental health,X29171.Frequency of feeling 'in tune' with people,34380,0.00204758570388883,0.0820565983132834,-0.158783346990147,0.162878518397924,0.980093047637737
LYZL2,Lysozyme-like protein 2,Mental health,X29172.Freuency of feeling that lacks companionship,34491,-0.0425104168250205,0.0783301901804078,-0.19603758957862,0.111016755928579,0.587351434693516
LYZL2,Lysozyme-like protein 2,Mental health,X29173.Frequency of feeling left out,34466,-0.0174344996870375,0.0801371312111689,-0.174503276860929,0.139634277486854,0.827780829946056
LYZL2,Lysozyme-like protein 2,Mental health,X29174.Frequency of feeling isolated from others,34495,-0.0332030602689777,0.0826507637330246,-0.195198557185706,0.12879243664775,0.687899366439751
LYZL2,Lysozyme-like protein 2,Mental health,X29175.Tendency to bounce back quickly after hard times,34540,-0.0227306165188821,0.0663810711822884,-0.152837516036167,0.107376282998403,0.732042312109615
LYZL2,Lysozyme-like protein 2,Mental health,X29176.Ability to make it through stressful events,34540,-0.0734264249708703,0.0644490270771695,-0.199746518042123,0.0528936681003819,0.254626287425174
LYZL2,Lysozyme-like protein 2,Mental health,X29177.Quick recovery from stressful events,34540,0.162278897887118,0.0670044306513876,0.0309502138103987,0.293607581963838,0.0154688056601332
LYZL2,Lysozyme-like protein 2,Mental health,X29178.Hard to snap back when something bad happens,34540,-0.0533553432610065,0.0644316277010325,-0.17964133355503,0.0729306470330172,0.407651441190659
LYZL2,Lysozyme-like protein 2,Mental health,X29179.Comes through difficult times with little trouble,34540,0.0375605906873625,0.066760892263922,-0.0932907581499246,0.16841193952465,0.573719223332579
LYZL2,Lysozyme-like protein 2,Mental health,X29180.Tendency to take a long time to get over setbacks,34540,-0.00376293060600847,0.0649508028110081,-0.131066504115584,0.123540642903567,0.953802281997549
LYZL2,Lysozyme-like protein 2,Mental health,X29181.General happiness,34508,0.0963910545444272,0.0672181396198081,-0.0353564991103967,0.228138608199251,0.15162419287382
LYZL2,Lysozyme-like protein 2,Mental health,X29182.Belief that own life is meaningful,34433,-0.0223845862608263,0.06842368457612,-0.156495008030021,0.111725835508369,0.743568636742231
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,33827,-0.0665167829348571,0.0725927999895063,-0.208798670914289,0.0757651050445753,0.359551845876638
LYZL2,Lysozyme-like protein 2,Health and medical history,X2946.Father's age,32743,0.00477235396550722,0.00857925944651614,-0.0120429945496644,0.0215877024806789,0.578058778716367
LYZL2,Lysozyme-like protein 2,Health and medical history,X2966.Age high blood pressure diagnosed,34346,-0.0123113008350218,0.00670444486501272,-0.0254520127704467,0.000829411100403172,0.0663665045918417
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,47815,0.0111688419667835,0.00284528818151103,0.00559207713102189,0.0167456068025451,8.6894187853703e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,47816,0.0182457653600589,0.00307905847053582,0.0122108107578087,0.0242807199623091,3.16159800752442e-09
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30020.Haemoglobin concentration,47816,0.010361454478097,0.00326381451206566,0.0039643780344483,0.0167585309217457,0.0015025623259352
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30030.Haematocrit percentage,47816,0.00929680597970275,0.00320191430403272,0.00302105394379861,0.0155725580156069,0.00369419291322346
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30040.Mean corpuscular volume,47816,-0.0160046325780278,0.00281559664568753,-0.0215232020035754,-0.0104860631524803,1.33271798555077e-08
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,47816,-0.0131994083314859,0.0028249917817197,-0.0187363922236565,-0.00766242443931529,2.99760989103445e-06
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,47816,0.00160266480755478,0.00275928436333337,-0.00380553254457863,0.00701086215968818,0.561364368695223
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,47816,-0.00783753006376448,0.00287744360443308,-0.0134773195284533,-0.00219774059907565,0.00645973332377401
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30080.Platelet count,47816,0.021510555146656,0.00281989057675707,0.0159835696162122,0.0270375406770999,2.49218291975934e-14
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30090.Platelet crit,47816,0.0308260946316528,0.00286740570095864,0.0252059794577739,0.0364462098055317,7.02755209073129e-27
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,47816,0.00920258072328328,0.00266178520455766,0.00398548172235027,0.0144196797242163,0.000546804651767784
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30110.Platelet distribution width,47816,0.00868543081971069,0.00274490532757409,0.00330541637766547,0.0140654452617559,0.00155751966603684
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30120.Lymphocyte count,47784,0.0157822099335099,0.00276669466575103,0.0103594883886379,0.0212049314783819,1.18504006303859e-08
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30130.Monocyte count,47784,-0.0015780089561669,0.00278092501297089,-0.00702862198158984,0.00387260406925604,0.570421708364339
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30140.Neutrophill count,47784,0.00781468468073537,0.002818258944606,0.00229089714930762,0.0133384722121631,0.00556167810900386
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30150.Eosinophill count,47784,0.0107323426548162,0.0026722733557764,0.00549468687749448,0.015969998432138,5.9373171708598e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30160.Basophill count,47784,0.0657547122573244,0.040088302669256,-0.0128183609744173,0.144327785489066,0.10097024702139
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30170.Nucleated red blood cell count,47784,-0.582556193773283,0.238895312874309,-1.05079100700693,-0.114321380539637,0.0147556635484201
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30180.Lymphocyte percentage,47785,0.00622537647697721,0.00274414522836829,0.000846851829375349,0.0116039011245791,0.0233035311722326
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30190.Monocyte percentage,47785,-0.0107710965588741,0.00274651784162897,-0.0161542715284669,-0.00538792158928135,8.82219793855203e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30200.Neutrophill percentage,47785,-0.00258991991237044,0.00270955956876298,-0.00790065666714589,0.00272081684240501,0.339162416933473
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30210.Eosinophill percentage,47785,0.00688572461891786,0.00265063670354319,0.00169047667997321,0.0120809725578625,0.00939050519189611
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30220.Basophill percentage,47785,0.00243561168125054,0.00278101209685322,-0.00301517202858178,0.00788639539108286,0.381149483350695
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,47784,-0.576985320865676,0.238732304850675,-1.044900638373,-0.109070003358352,0.0156638073432003
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30240.Reticulocyte percentage,47479,0.00466911478726916,0.00291629773188734,-0.00104682876723003,0.0103850583417683,0.109384376355984
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30250.Reticulocyte count,47479,0.00845052085869929,0.0029489878482073,0.00267050467621299,0.0142305370411856,0.00416723488001659
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30260.Mean reticulocyte volume,47479,-0.0118598496452077,0.00276485131731656,-0.0172789582271482,-0.00644074106326726,1.79960081238359e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30270.Mean sphered cell volume,47479,-0.0168793632803818,0.00277549134628575,-0.0223193263191019,-0.0114394002416618,1.21296315796426e-09
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30280.Immature reticulocyte fraction,47479,-0.00417084869401185,0.00287371467815521,-0.00980332946319606,0.00146163207517235,0.146691012872545
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,47479,0.00169617020071443,0.00295459248650797,-0.0040948310728412,0.00748717147427005,0.565921022182955
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30300.High light scatter reticulocyte count,47479,0.00484240027648862,0.00297008027985409,-0.000978957072025391,0.0106637576250026,0.103034989885934
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30500.Microalbumin in urine,35655,-0.00124821291522482,0.00429863226291709,-0.00967353215054233,0.00717710632009268,0.771538333910581
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,47853,-0.00522924234211579,0.00296019434612328,-0.0110312232605174,0.000572738576285834,0.0773245019150092
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30520.Potassium in urine,47818,-0.00520026286757012,0.00275996182536855,-0.0106097880452925,0.000209262310152234,0.0595558108217276
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30530.Sodium in urine,47823,-0.0073592284032204,0.00285824652591947,-0.0129613915940226,-0.00175706521241823,0.0100390907581799
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30600.Albumin,46029,0.0169193339844824,0.0029497201972025,0.0111378823979655,0.0227007855709993,9.85968442922617e-09
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30610.Alkaline phosphatase,47451,0.00993398740735475,0.00290695889653744,0.00423634797014137,0.0156316268445681,0.000633761778644831
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30620.Alanine aminotransferase,47436,0.00743424437437496,0.00312450936454508,0.00131020601986661,0.0135582827288833,0.0173539578601597
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30630.Apolipoprotein A,45976,-0.0139812158550923,0.00319405331995289,-0.0202415603622,-0.00772087134798468,1.20879531747491e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30640.Apolipoprotein B,47318,0.0053439384763506,0.00271584798039531,2.08764347757878e-05,0.0106670005179254,0.0491188157143362
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30650.Aspartate aminotransferase,47382,0.00744193805983418,0.00287402408935436,0.00180885084469964,0.0130750252749687,0.00962233332247481
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30660.Direct bilirubin,46143,-0.00486860775685274,0.00294390730013587,-0.0106386660651191,0.000901450551413573,0.0981878518884655
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30670.Urea,47440,0.00703764006835765,0.00286569574767043,0.00142087640292362,0.0126544037337917,0.014065219695188
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30680.Calcium,46022,0.0196792759635384,0.00292413616491718,0.0139479690803007,0.0254105828467761,1.75013546249702e-11
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30690.Cholesterol,47454,0.00297771165082068,0.00273949793946477,-0.00239170431053027,0.00834712761217164,0.277070485449226
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30700.Creatinine,47446,0.021191842170862,0.00361412151497309,0.0141081640015147,0.0282755203402092,4.60441473091032e-09
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30710.C-reactive protein,47381,-0.00293988101845059,0.00302062360342922,-0.00886030328117186,0.00298054124427068,0.330431879760142
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30720.Cystatin C,47459,0.014710325199144,0.0033133968719302,0.00821606733016079,0.0212045830681272,9.06163357442146e-06
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30730.Gamma glutamyltransferase,47442,0.00163602686019308,0.00329803124647249,-0.004828114382893,0.00810016810327915,0.619856693423427
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30740.Glucose,45999,-4.8716574144929e-05,0.00279565699487235,-0.00552820428409474,0.00543077113580488,0.986097122529293
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),47365,0.0113666546626935,0.00278794995770062,0.00590227274560026,0.0168310365797867,4.57956037537643e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30760.HDL cholesterol,46009,-0.0193933271885841,0.00329334307333311,-0.025848279612317,-0.0129383747648512,3.96538118210566e-09
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30770.IGF-1,47367,-0.000483951145970057,0.00291847274042483,-0.00620415771720272,0.0052362554252626,0.868297696980591
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30780.LDL direct,47410,0.00419022803767437,0.00273377670972065,-0.00116797431337811,0.00954843038872684,0.125351416269931
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30790.Lipoprotein A,43655,-0.000832822205453194,0.00300405323819117,-0.0067207665523079,0.00505512214140151,0.781605132523325
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30810.Phosphate,45982,0.0132979085104195,0.00284146455250538,0.00772863798750893,0.01886717903333,2.89110469462779e-06
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30830.SHBG,45904,-0.0118707316085832,0.00378168133676099,-0.0192828270286347,-0.00445863618853166,0.00169805143930212
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30840.Total bilirubin,47373,-0.00263703494969032,0.00297681292841317,-0.00847158828938014,0.0031975183899995,0.375705143869071
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30850.Testosterone,47270,0.00139579204235766,0.00465140844281289,-0.0077209685055556,0.0105125525902709,0.764119902060402
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30860.Total protein,45999,0.0156611692685498,0.00289921127861862,0.00997871516245726,0.0213436233746422,6.68149873845108e-08
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30870.Triglycerides,47432,0.027551261551896,0.00284643009331723,0.0219722585689942,0.0331302645347978,4.16002164320716e-22
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30880.Urate,47429,0.00649747793132618,0.00344126425950684,-0.00024740001730722,0.0132423558799596,0.0590268387176378
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30890.Vitamin D,46885,-0.00187595390345929,0.00308339685608874,-0.00791941174139322,0.00416750393447465,0.542926487963722
LYZL2,Lysozyme-like protein 2,Physical measures,X3137.Number of measurements made,46346,-0.0349412037004275,0.0478068163142577,-0.128642563676373,0.0587601562755176,0.464860086968221
LYZL2,Lysozyme-like protein 2,Physical measures,X3143.Ankle spacing width,39693,-0.0156570006476301,0.00503759502519802,-0.0255306868970182,-0.00578331439824202,0.00188814590449805
LYZL2,Lysozyme-like protein 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",39693,-0.00090707102659341,0.00364388702204113,-0.00804908958979403,0.00623494753660721,0.803419913107234
LYZL2,Lysozyme-like protein 2,Physical measures,X3146.Speed of sound through heel,39693,5.54658922563136e-05,0.00354024712082384,-0.00688341846455841,0.00699435024907104,0.98750014627476
LYZL2,Lysozyme-like protein 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",39693,-0.00027798087097665,0.00356844888940581,-0.00727214069421204,0.00671617895225874,0.937909293632681
LYZL2,Lysozyme-like protein 2,Physical measures,X3148.Heel bone mineral density (BMD),39675,0.00159478675553928,0.00358262593000736,-0.00542716006727514,0.0086167335783537,0.656223925383489
LYZL2,Lysozyme-like protein 2,Health and medical history,X3526.Mother's age at death,40381,-0.00429016501370506,0.003571188947745,-0.0112896953512853,0.00270936532387514,0.22964860624813
LYZL2,Lysozyme-like protein 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32245,0.00154276286976303,0.00624477636180268,-0.0106969987993702,0.0137825245388963,0.804884573314576
LYZL2,Lysozyme-like protein 2,Physical measures,X4100.Ankle spacing width (left),35043,-0.00844183952811067,0.00654836315113099,-0.0212766313043274,0.00439295224810607,0.197391312171782
LYZL2,Lysozyme-like protein 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),35041,0.00464596853509006,0.00473583976209817,-0.00463627739862235,0.0139282144688025,0.326618162183314
LYZL2,Lysozyme-like protein 2,Physical measures,X4103.Speed of sound through heel (left),35043,0.004974994125126,0.00454835965719631,-0.00393979080297876,0.0138897790532308,0.274083756069949
LYZL2,Lysozyme-like protein 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",35043,0.00473946913221513,0.00460820874017528,-0.00429261999852842,0.0137715582629587,0.303760803556073
LYZL2,Lysozyme-like protein 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),35036,0.00455743091932887,0.00462286904835903,-0.00450339241545482,0.0136182542541126,0.324246389320284
LYZL2,Lysozyme-like protein 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",35043,0.00474212101334269,0.00460854896683989,-0.00429063496166349,0.0137748769883489,0.303526037566083
LYZL2,Lysozyme-like protein 2,Physical measures,X4119.Ankle spacing width (right),35033,-0.0104548509331554,0.00645534727459673,-0.023107331591365,0.00219762972505423,0.105374889456549
LYZL2,Lysozyme-like protein 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),35032,0.00582313274640034,0.004775628222613,-0.00353709856992115,0.0151833640627218,0.222758436845208
LYZL2,Lysozyme-like protein 2,Physical measures,X4122.Speed of sound through heel (right),35033,0.00738814296518412,0.00452887215182797,-0.0014884464523987,0.0162647323827669,0.102866957116894
LYZL2,Lysozyme-like protein 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",35033,0.00717269200155697,0.00461306934939236,-0.00186892392325206,0.016214307926366,0.12002783332883
LYZL2,Lysozyme-like protein 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),35025,0.00753670557705194,0.00462652800026674,-0.00153128930347088,0.0166047004575748,0.103357858575601
LYZL2,Lysozyme-like protein 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",35033,0.0071707119815409,0.00461308699363532,-0.00187093852598433,0.0162123624890661,0.120131530291762
LYZL2,Lysozyme-like protein 2,Physical measures,X4194.Pulse rate,35361,-0.00954515377673685,0.00429677896075055,-0.0179668405398079,-0.00112346701366577,0.0263523208024297
LYZL2,Lysozyme-like protein 2,Physical measures,X4195.Pulse wave reflection index,35361,0.00523270999025239,0.00450209633181678,-0.00359139882010851,0.0140568188006133,0.245161558802021
LYZL2,Lysozyme-like protein 2,Physical measures,X4196.Pulse wave peak to peak time,35354,0.00523741658863992,0.00497847506705375,-0.00452039454278543,0.0149952277200653,0.292831581339596
LYZL2,Lysozyme-like protein 2,Physical measures,X4198.Position of the pulse wave peak,35361,-0.00832103978051977,0.00536493220849637,-0.0188363069091727,0.00219422734813312,0.120947152457052
LYZL2,Lysozyme-like protein 2,Physical measures,X4199.Position of pulse wave notch,35361,-0.00667685293835394,0.00434489376566829,-0.0151928447190638,0.00183913884235591,0.124410501575531
LYZL2,Lysozyme-like protein 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,35361,-0.0142209774592347,0.00546365764743242,-0.0249297464482022,-0.00351220847026714,0.00926593950093135
LYZL2,Lysozyme-like protein 2,Physical measures,X4269.Number of triplets attempted (left),35167,-0.0453125970071118,0.199583652561453,-0.43649655602756,0.345871362013337,0.820403131637208
LYZL2,Lysozyme-like protein 2,Physical measures,X4270.Volume level set by participant (left),35095,-0.072429921201374,0.0623965912446548,-0.194727240040897,0.0498673976381493,0.24576619796796
LYZL2,Lysozyme-like protein 2,Physical measures,X4276.Number of triplets attempted (right),35170,0.121707086603538,0.204001475065994,-0.278135804525811,0.521549977732887,0.550795700956718
LYZL2,Lysozyme-like protein 2,Physical measures,X4277.Volume level set by participant (right),35099,-0.0367428953270932,0.0611668083952715,-0.156629839781825,0.083144049127639,0.548060846712154
LYZL2,Lysozyme-like protein 2,Cognitive function,X4288.Time to answer,35331,-0.000177352310131376,0.00517196661873582,-0.0103144068828536,0.00995970226259083,0.97264605628875
LYZL2,Lysozyme-like protein 2,Cognitive function,X4290.Duration screen displayed,35331,-0.00997105119027702,0.00474666687632229,-0.0192745182678687,-0.000667584112685344,0.0357094444948693
LYZL2,Lysozyme-like protein 2,Physical measures,X46.Hand grip strength (left),48316,0.00506567615113528,0.00364092945638416,-0.00207054558337766,0.0122018978856482,0.164145926633987
LYZL2,Lysozyme-like protein 2,Physical measures,X47.Hand grip strength (right),48317,0.00480599081755478,0.00359620406948193,-0.00224256915862981,0.0118545507937394,0.181431835105999
LYZL2,Lysozyme-like protein 2,Physical measures,X48.Waist circumference,48368,-0.00228444861966231,0.00681797452467484,-0.015647678688025,0.0110787814487004,0.737581381317877
LYZL2,Lysozyme-like protein 2,Health and medical history,X4803.Tinnitus,35198,-0.0997373585285445,0.0716063992508577,-0.240085901060226,0.0406111840031365,0.163710477108797
LYZL2,Lysozyme-like protein 2,Working and living environment,X4825.Noisy workplace,35272,-0.015555640072842,0.0683334314922149,-0.149489165797583,0.118377885651899,0.819930620827631
LYZL2,Lysozyme-like protein 2,Working and living environment,X4836.Loud music exposure frequency,35228,0.0138016886459819,0.0906466810909751,-0.163865806292329,0.191469183584293,0.878988030909824
LYZL2,Lysozyme-like protein 2,Physical measures,X49.Hip circumference,48362,-0.0171430491665668,0.00500167734654573,-0.0269463367657964,-0.00733976156733719,0.00061049704324812
LYZL2,Lysozyme-like protein 2,Physical measures,X50.Standing height,48329,-0.00987730095552215,0.00377817897604571,-0.0172825317485717,-0.00247207016247255,0.00894778969178655
LYZL2,Lysozyme-like protein 2,Health and medical history,X5057.Number of older siblings,34503,0.0618211773647039,0.066429511613219,-0.0683806653972054,0.192023020126613,0.352083980721451
LYZL2,Lysozyme-like protein 2,Physical measures,X51.Seated height,48246,-0.00254199727402962,0.00328968291668896,-0.00898977579073998,0.00390578124268074,0.439698574940777
LYZL2,Lysozyme-like protein 2,Eye measures,X5181.Ever had eye surgery,33154,-0.122843044312961,0.157037126266178,-0.43063581179467,0.184949723168748,0.434105538956178
LYZL2,Lysozyme-like protein 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),33144,-0.00670236472758428,0.00546505720266034,-0.0174138768447986,0.00400914738962998,0.220110454141653
LYZL2,Lysozyme-like protein 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),33141,-0.00704000741313191,0.00561917265939173,-0.0180535858255397,0.00397357099927588,0.210323066512452
LYZL2,Lysozyme-like protein 2,Eye measures,X5190.Duration at which refractometer first shown (right),33096,-0.00737993997408415,0.00563222355629352,-0.0184190981444195,0.00365921819625115,0.190159054318757
LYZL2,Lysozyme-like protein 2,Eye measures,X5193.Duration at which refractometer first shown (left),33093,-0.00298469879466991,0.00569003888579132,-0.0141371750108209,0.00816777742148107,0.59992328738149
LYZL2,Lysozyme-like protein 2,Eye measures,"X5199.logMAR, initial (right)",33123,0.142525446044534,0.0791443861870933,-0.0125975508821684,0.297648442971237,0.0717965591354021
LYZL2,Lysozyme-like protein 2,Eye measures,X5200.Final number of letters displayed (right),33123,0.55611241529807,0.534298448707874,-0.491112544169362,1.6033373747655,0.298011360779497
LYZL2,Lysozyme-like protein 2,Eye measures,"X5201.logMAR, final (right)",33071,0.00375406638614001,0.00544723062730601,-0.00692250564337977,0.0144306384156598,0.490752234255882
LYZL2,Lysozyme-like protein 2,Eye measures,X5202.Number of rounds to result (right),33123,0.077540067457709,0.0740432145216461,-0.0675846330047174,0.222664767920135,0.295050902111368
LYZL2,Lysozyme-like protein 2,Eye measures,"X5206.logMAR, initial (left)",33119,0.0532622444917143,0.0773319738424038,-0.0983084242393971,0.204832913222826,0.491017211613689
LYZL2,Lysozyme-like protein 2,Eye measures,X5207.Final number of letters displayed (left),33119,-0.259823308267399,0.450533173129687,-1.14286832760159,0.623221711066788,0.564169628656183
LYZL2,Lysozyme-like protein 2,Eye measures,"X5208.logMAR, final (left)",33080,0.00322155369855686,0.00550384658418282,-0.00756598560644147,0.0140090930035552,0.558356893534657
LYZL2,Lysozyme-like protein 2,Eye measures,X5209.Number of rounds to result (left),33115,0.0386986664202824,0.0745798658413014,-0.107477870628668,0.184875203469233,0.603863694238787
LYZL2,Lysozyme-like protein 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",32951,0.00132424825483948,0.00546005984517889,-0.00937746904171114,0.0120259655513901,0.80837811589391
LYZL2,Lysozyme-like protein 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",32951,0.0041099121006457,0.0053703967135342,-0.00641606545788132,0.0146358896591727,0.444140252526328
LYZL2,Lysozyme-like protein 2,Eye measures,X5256.Corneal hysteresis (right),32951,0.0039604123973477,0.00557180394987083,-0.00696032334439913,0.0148811481390945,0.477249154729358
LYZL2,Lysozyme-like protein 2,Eye measures,X5257.Corneal resistance factor (right),32951,0.00513323854358322,0.00549908992908657,-0.00564497771742647,0.0159114548045929,0.350628862916736
LYZL2,Lysozyme-like protein 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",32929,0.00330132242820338,0.00546514198709625,-0.00741035586650526,0.014013000722912,0.545829474425715
LYZL2,Lysozyme-like protein 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",32929,0.0018321333088997,0.00543499831525615,-0.00882046338900234,0.0124847300068017,0.736058500595782
LYZL2,Lysozyme-like protein 2,Eye measures,X5264.Corneal hysteresis (left),32929,-0.00185133670930625,0.00546850797749331,-0.0125696123451931,0.00886693892658063,0.734968847031017
LYZL2,Lysozyme-like protein 2,Eye measures,X5265.Corneal resistance factor (left),32929,-0.00127371129053302,0.00546204127005178,-0.0119793121798345,0.00943188959876846,0.815622353029135
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,33691,0.280697238029625,0.359572269704494,-0.424064410591183,0.985458886650434,0.435049347768131
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",48324,-0.00288492379584332,0.0147551178156,-0.0318049547144194,0.0260351071227328,0.844987728434928
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",48324,-0.0370052451481612,0.0168114359551823,-0.0699556596203185,-0.00405483067600393,0.0277337781645132
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",48324,0.0120361703088433,0.0422151546107906,-0.0707055327283062,0.0947778733459929,0.775559095529561
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",48324,-0.0116662055424416,0.00671604476092337,-0.0248296532738514,0.00149724218896823,0.082391328920913
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",48324,0.0144768669165514,0.00622895777342397,0.00226810968064041,0.0266856241524624,0.0201289827098414
LYZL2,Lysozyme-like protein 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37255,0.00946662913905091,0.0080678954452013,-0.00634644593354364,0.0252797042116455,0.240679619397086
LYZL2,Lysozyme-like protein 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37255,-0.0304816988349793,0.0247828703883963,-0.0790561247962361,0.0180927271262774,0.218749147849511
LYZL2,Lysozyme-like protein 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37255,0.0144226842288849,0.0155155546398075,-0.0159878028651379,0.0448331713229077,0.352623359682517
LYZL2,Lysozyme-like protein 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37255,0.0156554988346245,0.00938633199212569,-0.00274171186994185,0.0340527095391909,0.0953709994075698
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,48381,-0.0109463564446032,0.0140965623113269,-0.038575618574804,0.0166829056855975,0.437447370911961
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,48381,-0.0109463564446032,0.0140965623113269,-0.038575618574804,0.0166829056855975,0.437447370911961
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),48381,0.00366417975945905,0.0102950317725665,-0.0165140825147713,0.0238424420336895,0.721906306128328
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',48381,-0.0140364669591016,0.018133751069667,-0.049578619055649,0.0215056851374457,0.438909269962935
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),48381,0.00752425252270871,0.0437227893211982,-0.0781724145468397,0.0932209195922571,0.863368575999257
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),48381,-0.0126094530068075,0.0302694578225874,-0.0719375903390787,0.0467186843254638,0.676994939596721
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,48381,0.0335361794472981,0.046389848130368,-0.0573879228882232,0.124460281782819,0.469737179406404
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,48323,0.00718892590838525,0.00917651853910153,-0.0107970504282538,0.0251749022450243,0.433399022018977
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,48323,0.00330658414752915,0.0160048710087216,-0.0280629630295653,0.0346761313246236,0.836325476392519
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,48323,6.18329097945399e-05,0.00833298136488773,-0.0162708105653854,0.0163944763849745,0.994079616428806
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,48323,0.00655775206162056,0.0122745240214072,-0.0175003150203375,0.0306158191435786,0.593169664816227
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,48323,0.00822149689548382,0.0124424741812222,-0.0161657524997116,0.0326087462906792,0.508773561573931
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,48323,-0.00934685389987895,0.0070772568714646,-0.0232182773679496,0.00452456956819167,0.186620473208973
LYZL2,Lysozyme-like protein 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,35684,0.00749712528622111,0.0134488424286132,-0.0188626058738607,0.0338568564463029,0.577234167737665
LYZL2,Lysozyme-like protein 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,35684,0.00593465485170263,0.0128864281890461,-0.0193227443988277,0.031192054102233,0.645146188441647
LYZL2,Lysozyme-like protein 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,35684,-0.00209179814845107,0.0186568134405408,-0.038659152491911,0.0344755561950089,0.910731596782442
LYZL2,Lysozyme-like protein 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,35684,-0.00310081177741696,0.0138516089558689,-0.03024996533092,0.024048341776086,0.82287322486823
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,48281,-0.0249915957360934,0.0246827761240236,-0.0733698369391797,0.0233866454669929,0.311305977789039
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,48281,-0.00825852885741789,0.0308002871432859,-0.0686270916582583,0.0521100339434226,0.788600868257129
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,48281,0.0326000127481682,0.0577856918611057,-0.080659943299599,0.145859968795935,0.572655952922345
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,48281,0.027711604180432,0.056402719899362,-0.0828377268223176,0.138260935183182,0.623207874042215
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,48281,0.0117992508115779,0.023293598091052,-0.033856201446884,0.0574547030700398,0.612479927708166
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,48281,0.0479477029068308,0.0273706396026502,-0.00569875071436363,0.101594156528025,0.0798249318706831
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,48281,-0.0114934887112653,0.0115704630648596,-0.0341715963183902,0.0111846188958596,0.320552927100718
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",34538,-0.0285078412394189,0.0192894536524832,-0.066315170398286,0.00929948791944818,0.139488170419675
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",34538,-0.00188376345813708,0.0186779948270619,-0.0384926333191784,0.0347251064029043,0.919669213347299
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",34538,-0.0542304359569837,0.0271347176645462,-0.107414482579494,-0.00104638933447312,0.0457011956953954
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",34538,0.00481861002253491,0.0096962040979615,-0.0141859500094696,0.0238231700545395,0.619236789295916
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",37156,0.0107891860386457,0.00839423861241012,-0.00566352164167814,0.0272418937189695,0.198719298939691
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",37156,-0.00128768631085565,0.00926152954840668,-0.0194402842257327,0.0168649116040215,0.889424949064802
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",37156,0.0045432283904666,0.00820819574147927,-0.0115448352628328,0.020631292043766,0.579936206732618
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",37157,-0.0166446182407681,0.0190315601527068,-0.0539464761400735,0.0206572396585374,0.381827123345942
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",37157,-0.00160604523378379,0.0113883790559543,-0.0239272681834542,0.0207151777158866,0.887853576133364
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",37157,-0.00438487877882853,0.0208300408516584,-0.045211758848079,0.036442001290422,0.83327665002466
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,48323,-0.00496714667332411,0.0181050168566586,-0.0404529797123749,0.0305186863657267,0.783817038672032
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,48323,-0.0170816470668662,0.0145657928828909,-0.0456306011173324,0.0114673069836,0.240920882933602
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,48323,-0.0152267079535347,0.0300908273438417,-0.0742047295474645,0.0437513136403951,0.612844824112907
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,48323,-0.0265514244177375,0.016292931183482,-0.0584855695373623,0.00538272070188728,0.103196014121825
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,48323,-0.000792506719179122,0.0166754667841209,-0.0334764216160561,0.0318914081776978,0.962095040288817
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),48323,0.00727254113558272,0.0201383941590023,-0.0321987114160619,0.0467437936872273,0.718007514470571
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,48323,0.0159905210603122,0.00588076703477994,0.00446421767214349,0.0275168244484809,0.00655127889151734
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,33301,-0.001591713077623,0.0137824609357292,-0.0286053365116523,0.0254219103564063,0.908063020827385
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,33301,-0.010391260588118,0.0166758852970608,-0.0430759957703571,0.0222934745941211,0.533228687784612
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,33301,-0.0176782387480257,0.0124120567758409,-0.0420058700286739,0.00664939253262253,0.154431937048622
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,33301,0.0199487585577096,0.0111011466980565,-0.00180948897048119,0.0417070060859004,0.0723998131841867
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,48409,0.00864276967676013,0.0071379868437671,-0.0053476845370234,0.0226332238905437,0.225981397929545
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,48409,0.0162301896920684,0.0232489422999309,-0.0293377372157962,0.061798116599933,0.485120080166189
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,48409,-0.00183252405814781,0.00630179063918909,-0.0141840337109584,0.0105189855946628,0.771211779089674
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,48409,0.00266250878763286,0.00590208117753062,-0.00890557032032716,0.0142305878955929,0.651912650933428
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,48409,-0.00628144808864571,0.0100531892165014,-0.0259856989529884,0.013422802775697,0.532095459056882
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,48409,-0.0040829554004278,0.00896180926359712,-0.0216481015570782,0.0134821907562226,0.648686240402456
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,48409,-0.000960000027285852,0.00636411282503459,-0.0134336611643536,0.0115136611097819,0.880098850625571
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,48409,-0.0191513098716553,0.0206443776006598,-0.0596142899689485,0.021311670225638,0.353586556132959
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,42369,-0.00865690746777701,0.0065830356893541,-0.021559657418911,0.00424584248335702,0.18852079902761
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,42369,0.00627211604986259,0.00648245667213093,-0.00643349902751403,0.0189777311272392,0.33328498928368
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,42369,-0.00252041919080696,0.00837118657482045,-0.018927944877455,0.0138871064958411,0.763356003210256
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,42370,-0.0153265974621358,0.0130049521466807,-0.04081630366963,0.0101631087453585,0.238609689904262
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,42370,0.0162681929753365,0.00743122355170406,0.00170299481399653,0.0308333911366764,0.0286013972667545
LYZL2,Lysozyme-like protein 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,48227,0.00934016749710326,0.00675640204413871,-0.00390238050940862,0.0225827155036151,0.166859317858205
LYZL2,Lysozyme-like protein 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,48227,-0.00646338594874204,0.00530392651326212,-0.0168590819147358,0.00393231001725172,0.223009185332952
LYZL2,Lysozyme-like protein 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,48227,2.84279649120419e-05,0.00599902283953487,-0.0117296568005763,0.0117865127304004,0.996219074156565
LYZL2,Lysozyme-like protein 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,48227,-0.000710069521192152,0.00916910160143644,-0.0186815086600076,0.0172613696176233,0.938273070245514
LYZL2,Lysozyme-like protein 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),48245,0.00418356954466388,0.00570387565346787,-0.00699602673613314,0.0153631658254609,0.46328614367418
LYZL2,Lysozyme-like protein 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,48245,0.00945872812643466,0.00798219419531276,-0.00618637249637836,0.0251038287492477,0.236040301048174
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),48323,0.00271799845544504,0.00584010824963015,-0.00872861371383005,0.0141646106247201,0.641648692288686
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,48323,-0.00561044158955545,0.00733975346910715,-0.0199963583890055,0.00877547520989457,0.444643407555729
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,48323,-0.0143334939879502,0.015472033880516,-0.0446586803937616,0.0159916924178612,0.354242703998754
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,48323,-0.00570298622606032,0.0145165537029144,-0.0341554314837725,0.0227494590316518,0.694426473963262
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,48323,-0.00726558019507473,0.0174363506498772,-0.041440827468834,0.0269096670786845,0.676908561445879
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,48323,-0.032608856387408,0.0176975172788954,-0.067295990254043,0.00207827747922698,0.0654072958369977
LYZL2,Lysozyme-like protein 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",39693,-0.000278573168065103,0.00356845897526854,-0.00727275275959144,0.00671560642346123,0.937777440019154
LYZL2,Lysozyme-like protein 2,Physical activities,X864.Number of days or week walked 10+ minutes,48021,-0.0175420696933411,0.0356998491768262,-0.0875137740799204,0.0524296346932382,0.623165682145084
LYZL2,Lysozyme-like protein 2,Physical activities,X874.Duration of walks,45787,0.000137385127578957,0.00274275883797866,-0.00523842219485922,0.00551319245001713,0.960051152622293
LYZL2,Lysozyme-like protein 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,47497,-0.0673582822380595,0.0343366893062823,-0.134658193278373,-5.83711977462098e-05,0.0498120884846234
LYZL2,Lysozyme-like protein 2,Physical activities,X894.Duration of moderate activity,43468,0.00885361856951082,0.0413482811740989,-0.0721890125317231,0.0898962496707447,0.830454066253695
LYZL2,Lysozyme-like protein 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,32471,0.00110423690571501,0.0063238539849371,-0.0112905169047617,0.0134989907161917,0.861391648080432
LYZL2,Lysozyme-like protein 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,47430,-0.0384719446713176,0.0352974939288617,-0.107655032771886,0.0307111434292514,0.275756096382583
LYZL2,Lysozyme-like protein 2,Physical activities,X914.Duration of vigorous activity,39862,-0.00449516606793212,0.00331673610384193,-0.0109959688314623,0.00200563669559807,0.175349787688452
